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Bioenergetics and Electron Transfer Chain 
 Living cells require a continual input of energy to maintain the living state. More 
than 90% of the energy needed for aerobic cells is provided through a process known as 
oxidative phosphorylation. This process is carried out in the inner mitochondrial 
membrane by the electron transfer chain and adenosine triphosphate (ATP) synthase (1,2) 
(see Figure 1).                           
 The electron transfer chain is composed of four enzyme complexes: 
NADH:ubiquinone oxidoreductase (complex I), succinate:ubiquinone oxidoreductase 
(complex II), cytochrome bc1 complex (ubiquinol:cytochrome c oxidoreductase or 
Complex III), and cytochrome c oxidase (complex IV). Electrons are passed through these 
complexes from lower to higher standard reduction potentials. Complex I catalyzes the 
transfer of electrons from reduced nicotinamide adenine dinucleotide (NADH) to 
coenzyme Q (CoQ). Complex II catalyzes the oxidation of flavin adenine dinucleotide 
(FADH2) by CoQ. Since this redox reaction does not release sufficient free energy to 
synthesize ATP, complex II functions only to extract the electrons from FADH2 and 






Figure 1.  The enzymes of the mitochondrial inner membrane involved in oxidative 
phosphorylation. The oxidation of NADH and FADH2 is catalyzed by the respiratory or 
electron transport chain, a series of four enzyme complexes: NADH:ubiquinone 
oxidoreductase (complex I), succinate:ubiquinone oxidoreductase (complex II), 
cytochrome bc1 complex (ubiquinol:cytochrome c oxidoreductase or complex III) and 
cytochrome c oxidase (complex IV). The other complex is the ATP synthase (complex V), 
which catalyzes the synthesis of ATP from ADP and inorganic phosphate (Pi). 
3 
which catalyzes the oxidation of reduced CoQ by cytochrome c. Reduced cytochrome c is 
finally oxidized by donating the electrons to molecular oxygen by complex IV producing 
water. Electrons transferred through complexes I, III and IV are accompanied with 
translocation of protons across the mitochondrial inner membrane to generate a proton 
gradient and a membrane potential used by ATP synthase (complex V) that synthesize 
ATP from ADP and inorganic phosphate (Pi). The chemiosmotic theory (3) proposed by 
the Nobel Prize laureate Peter Mitchell is the general mechanistic principle of oxidative 
and phosphorylation. It explains the coupling between respiration and ATP synthesis and 
has become a paradigm in the intellectual framework of bioenergetics since the mid-
1970’s. To this date, the electron transfer and proton translocation in the electron transfer 
chain are the main points of bioenergetics. 
 
NADH:Ubiquinone Oxidoreductase 
 The Function and Subunit Composition of NADH:Ubiquinone Oxidoreductase-- 
NADH:ubiquinone oxidoreductase (commonly known as complex I) is the first segment of 
the energy-conserving electron transfer chains of mitochondria and many respiratory and 
some bacteria (4) (see Figure1). This complex catalyzes electron transfer from NADH to 
ubiquinone (Q) and concomitantly translocates protons across the membrane to generate a 
membrane potential and proton gradient  for ATP synthesis (5,6). Forty-six different 
subunits have been identified in complex I from bovine heart mitochondria with a 
molecular mass of almost 1000 kDa (7). Seven subunits (ND1 to ND6 plus ND4L) are 
products of the mitochondrial genome (8,9). The rest are nuclear gene products that are 
imported into the mitochondria from the cytoplasm (10). The bacterial complex I has a 
4 
mass close to 550 kDa and contains only 13 or 14 subunits (designated NuoA-N for 
Escherichi (E.) coli and Nqo1-14 for Paracoccus denitrificans and Thermus thermophilus) 
(6,11). All of the subunits of bacterial complex I have analogues in the mitochondrial 
enzyme (4) (see Table 1). Because the subunit composition of complex I from bacteria is 
relatively simple compared to that of its mitochondrial counterpart, the bacterial enzyme is 
a useful model system for studying the structure and function of complex I (12).  
The Structures of Complex I--Unlike other electron-transport chain complexes, 
the X-ray crystal structure of complex I is not available at this moment because of its 
complexity. However, electron microscopy (EM)  analysis of two dimensional crystals has 
shown that both the mitochondrial and the bacterial enzyme have two arms arranged 
perpendicular to each other forming a characteristic L-shaped structure (11). A model for 
the architecture of this enzyme is illustrated in Fig. 2A. One arm is embedded in the 
mitochondrial inner membrane, the other, so called the peripheral arm, protrudes into the 
mitochondrial matrix or bacterial cytoplasm. This was demonstrated at about 20 to 30 Å 
resolution for the enzyme from fungus Neurospora crassa (13,14), yeast Yarrowia 
lipolytica (15), beef heart mitochondria (16), E. coli  (11,17), and the thermophile Aquifex 
aeolicus (18). Recently, however, Dr. Friedrich’s group reported that E.  coli complex I 
has an additional stable conformation, with the two arms arranged side by side, resulting in 
a horseshoe-shaped quaternary structure (see Fig. 2B). The global L-shaped conformation 
existed under high ionic strength conditions and the “horseshoe”-like conformation at low 
ionic strength. The transition between these two comformations was reversible. This 




Table 1: Subunits and cofactors of complex I 
Bovine 
complex I 






Cofactors Fe-S center Em (mV) 
51 K NuoF Nqo1 FMNb  -340 
   [4Fe-4S] N3 -250 
24 K NuoE Nqo2 [2Fe-2S] N1a -370 
75 K NuoG Nqo3 [2Fe-2S] N1b -250 
   [4Fe-4S] N4 -250 
   [4Fe-4S] N5 -250 
   [4Fe-4S] N1cc N/A 
49 K NuoDa Nqo4   N/A 
30 K NuoCa Nqo5   N/A 
PSST NuoB Nqo6 [4Fe-4S] N2 -50 to -150 
TYKY NuoI Nqo9 2[4Fe-4S] N6 N/A 
ND1 NuoH Nqo8   N/A 
ND2 NuoN Nqo14   N/A 
ND3 NuoA Nqo7   N/A 
ND4 NuoM Nqo13   N/A 
ND4L NuoK Nqo11   N/A 
ND5 NuoL Nqo12   N/A 
ND6 NuoJ Nqo10   N/A 
> 32 other 





a In some species of bacteria, for example E. coli, NuoC and NuoD are fused. b FMN is 
flavin mononucleotide. cThis [4Fe-4S] cluster is only present in some species of bacteria 







Figure 2. Speculative conformational models of complex I from E. coli  in a buffer of 
high (A) and low (B) ionic strength (19). The soluble NADH dehydrogenase module 
comprising subunits NuoE, -F, and -G is drawn in yellow.  All subunits of the connecting 
fragment (NuoB, -CD, and –I) together with the hydrophobic subunits NuoH and -L of the 
membrane fragment constitute the so-called hydrogenase module shown in red. The 
remaining subunits of the membrane fragment, namely NuoA, -J, -K, -M, and -N, build the 




 NADH:ubiquinone oxidoreductase activity solely in this conformation (19). 
Subfraction of complex I with chaotropes and detergents indicates that all the 
redox centers of the enzyme (flavin mononucleotide (FMN) and up to 8-9 iron-sulfur [Fe-
S] clusters) are located in the peripheral arm (10,11,20,21) (Table 1). The peripheral arm 
of bovine enzyme has been resolved into two fractions, a flavoprotein fraction and an iron-
sulfur protein fraction. The main components of the flavoprotein fraction are the 51-kDa 
(NuoF in E. coli) and 24-kDa (NuoE) subunits, whereas the iron-sulfur protein fraction 
comprises mainly the 75- (NuoG), 49-, and 30-kDa (NuoCD, fused in E. coli) and PSST 
(NuoB) subunits (22). With the E. coli enzyme, the peripheral arm is resolved into a 
NADH dehydrogenase fragment and a connecting fragment (23). The soluble NADH 
dehydrogenase fragment is the electron input part of the complex, which comprises the 
subunits NuoE, NuoF and NuoG as well as harbors the FMN, and the electron 
paramagnetic resonance (EPR)-detectable FeS clusters of N1a, N1b, N1c, N3, and N4 
(21). The NuoF subunit contains the NADH-binding site as it has been shown for complex 
I from beef heart (24) by photoaffinity labeling using arylazido-beta-[3-3H]-alanyl NAD+. 
The connecting fragment consists of NuoB, NuoCD and NuoI (bovine TYKY) 
subunits and contains the EPR-detectable FeS cluster N2 and the UV-visible-detectable 
clusters N6a and N6b (25). 
The membrane arm of the enzyme, which seemingly lacks known cofactors, such 
as flavin or iron-sulfur clusters, has been studied far less than the peripheral arm. 
However, the membrane arm of bovine complex I was resolved into two subcomplexes, 
designated Iβ and Iγ (20,26). The Iβ fragment contains subunits ND4 (NuoM in E. coli) 
and ND5 (NuoL) along with 11 accessory subunits, which do not directly participate in the 
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electron and proton transport function. The Iγ fragment is composed of ND1 (NuoH), ND2 
(NuoN), ND3 (NuoA), and ND4L (NuoK) along with 1 accessory subunit. Recently, the 
membrane arm of complex I from E. coli has been disrupted into fragments containing 
NuoL/M/N, NuoA/K/N, and NuoH/J subunits, respectively (27). Sequence comparisons 
have suggested that subunits ND2 (NuoN), ND4 (NuoM) and ND5 (NuoL) evolved from a 
common ancestor related to K+ or Na+/H+ antiporters and thus are likely to be involved in 
the proton translocation (28).  
 The Interaction between Q and Complex I--The mechanisms of electron transfer 
and proton translocation in complex I is poorly understood. The interaction between 
complex I and Q is the central part of the enzymatic mechanism of this complex since Q is 
the final electron acceptor in this enzyme complex and may take part in electron recycling 
and/or proton transport processes. At the present time, the number or location of the Q-
binding sites in this complex is still under debate (29,30); up to three sites have been 
proposed (31). The Q-binding site has long been thought to be located at the membrane 
arm due to its lipophilic nature. ND1 (NuoH in E. coli) was identified as a Q- and 
rotenone-binding protein by photoaffinity labeling using two rotenone analogs (32,33). 
The result of rotenone binding was used to indicate that Q binds to the same site. 
Pyridaben is another potent inhibitor of complex I. Using a pyridaben photoaffinity ligand 
the hydrophilic subunit PSST (NuoB in E. coli) was specifically labeled (34). The PSST 
subunit was proposed to house iron-sulfur cluster N2, which has the highest redox 
potential (see Table 1) and is therefore considered to be the site of electron transfer to the 
Q molecules (35). Fenpyroximate has been established to be a potent inhibitor of complex 
I (36,37). ND5 (NuoL) subunit was indicated as one of the  possible candidates 
9 
representing a Q-binding site since it was specifically labeled by 
[3H](trifluoromethyl)phenyldiazirinylfenpyroximate (38). 
Another approach to locate the Q-binding site involved the use of bioinformatics 
(39). On the basis of the known 3D structures of enzyme complexes bearing Q, the 
following sequence motifs of Q-binding sites were deduced: L-(X)3-H-(X)2-3-T/S or A/L-
(X)3-H-(X)2-L. A search of the SWISSPROT database identified that the sequence L-(X)3-
H-(X)3-S was located in a well-conserved region of a diverse range of ND4 (NuoM in E. 
coli) sequences. The histidine residue was fully conserved and the triad itself was 
conserved in 96% of the 71 full-length sequences in the database. Alignment of 
representative ND4 (NuoM) and ND5 (NuoL) sequences indicates that a histidine residue 
(His328 in the bovine sequence) is also fully conserved in the equivalent position in the 91 
full-length ND5 sequences. The triad sequence around the histidine residue in ND5 is most 
commonly (59%) the L-(X)3-H-(X)2-T. Taking these bioinformatics together, ND4 
(NuoM)/ND5 (NuoL) are considered to be candidates for the locations of Q-binding sites 
in complex I. The ND4 (NuoM)/ND5 (NuoL) pair might harbor two separate Q sites or a 
single site could be formed from elements of both subunits. 
Mutational analysis is the third powerful method to obtain the information about 
the Q-binding site(s). Several subunits were identified as the Q-binding site(s) in complex 
I based on the mutational studies. Human mutation on ND1 (NuoH) was reported to have a 
marginal effect on the NADH-dependent respiration and this effect was taken as genetic 
indication for the involvement of ND1 in the binding of Q (40-42).  ND4 (NuoM) and the 
ND5 (NuoL) subunits were suggested as the Q-binding sites based on the fact that null 
mutants lacking the ND4 (NuoM) and the ND5 (NuoL) subunits had NADH-K3Fe(CN)6 
10 
reductase activity but lack NADH-ubiquinone reductase activity (43,44). Additionally, 49-
kDa subunit (NuoD) was proposed to be involved in Q binding due to the inhibitor 
resistance conferred by a point mutation in this subunit (45). 
             Thus, the Q-binding site is most likely involved in NuoB (PSST), NuoD (49-kDa), 
NuoH (ND1), NuoM (ND4) and NuoL (ND5) in complex I. To unambiguously identify 
the Q-binding site(s) in this complex, we used a labeled azido-Q derivative, 3-azido-2-
methyl-5-methoxy[3H]-6-decyl-1,4-benzoquinone ([3H]azido-Q), to study the interaction 
between Q and complex I from E. coli through photoaffinity labeling (46). Contrary to the 
experiments carried out previously, NuoM subunit was identified as the Q-binding site. 
Because the binding of [3H]azido-Q was not affected by addition of inhibitors, the 
inhibitor binding site(s) might not be identical to the Q binding site(s) although these 
binding site(s) for inhibitors were partially overlapped. The detailed conditions for 
photoaffinity labeling of this enzyme with [3H]azido-Q and the isolation procedure for the 
Q-binding peptide will be presented in Chapter II of this thesis. 
Supernumerary Subunits in Complex I--As described above, mitochondrial 
complex I has at least 32 more subunits than its bacterial counterpart. These “extra” 
subunits are called “accessory” or “supernumerary”. Although the function of 
supernumerary subunits is not fully understood, it has been speculated that these subunits 
form a scaffold around the 14 minimal subunits preventing the high energy electrons from 
escaping the complex to react with oxygen to generate reactive oxygen species (11). 
Using the technique of gene manipulation, Videira et al. (47,48) constructed null 
mutants of several Neurospora (N.) crassa supernumerary subunits and their effects on 
complex I were investigated (see Table 2). In some cases, like mutants nuo21.3b, nuo20.9, 
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nuo20.8, nuo19.3 and nuo12.3, the membrane arm was disrupted although the peripheral 
arm of complex I could still be formed. In the other case, like mutant nuo29.9, the 
peripheral arm seems to be totally disrupted without interference with the formation of the 
membrane arm of the enzyme. In the case of the ACP mutant, the peripheral arm seems to 
be totally disrupted and the membrane arm of complex I cannot assemble properly. All of 
these data indicate that subunits 29.9/B13, 21.3b/B14.7, 20.9, 20.8/PGIV, 19.3/PEST, 
12.3/PDSW, and ACP/SDAP have a role in the assembly and/or stability of complex I. 
A possible role for the 39K supernumerary subunit in bovine complex I (40K in N. 
crassa) was also investigated. Complex I isolated from N. crassa contains tightly bound 
NADPH and further experiments with null mutants suggest that this tightly bound 
NADPH of complex I is present in the N. crassa 40K subunit (49). Furthermore, the 
finding of 39K  subunit of bovine complex I (40K in N. crassa) can be labeled by 
[32P]NADPH (50) supports that this subunit has NADPH-binding activity which may be 
involved in intramitochondrial fatty acid synthesis (4). These observations point to the 
presence of NADH/NADPH-binding sites other than the substrate NADH-binding site. 
The MWFE subunit, a short protein composed of 70 amino acid residues, was 
imported into mitochondria and assembled into complex I without requiring proteolytic 
processing. Two of the mutations of this subunit in Chinese hamster cell, a conservative 
substitution (R50K) and a short C-terminal deletion, make complex I completely inactive 
(51). In fact, in the absence of MWFE, complex I was not even detectable by blue native 
gel electrophoresis. On the basis of these data it can be concluded that the MWFE subunit 





Table 2: Properties of supernumerary subunits as determined by  










40 39K peripheral no 
29.9 B13 peripheral yes 
21.3a  peripheral no 
21.3b B14.7  membrane yes 
21 AQDQ peripheral no 
20.9   membrane yes 
20.8 PGIV  membrane yes 
19.3 PEST peripheral Yes 
12.3 PDSW  membrane Yes 
ACP SDAP peripheral Yes 
9.8 MWFE  membrane Unknown 
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Cytochrome bc1 Complex 
The Function and Subunits of the Cytochrome bc1 Complex--The cytochrome bc1 
complex is an essential segment of the electron transfer chains of mitochondria (see Figure 
1) and many respiratory and photosynthetic bacteria. This complex catalyzes electron 
transfer (ET) from ubiquinol to cytochrome c with concomitant translocation of protons 
across the inner mitochondrial or bacterial plasma membrane to generate a proton gradient 
and membrane potential for ATP synthesis (52,53).  
All the cytochrome bc1 complexes share three core subunits carrying prosthetic 
groups. These are b-type cytochrome with one low potential heme (bL or b566) and one 
high potential heme (bH or b562), one c-type cytochrome with a covalently attached heme 
c1, and the Rieske iron sulfur protein (ISP) containing a high potential Rieske [2Fe-2S] 
cluster (54-56). These three subunits form a monomer that dimerizes to yield an active 
cytochrome bc1 with two active sites per monomer, referred to as Qo (QH2 oxidation) and 
Qi (Q reduction) sites. The Qo site, where QH2 is oxidized to Q, is near the positive side of 
the membrane (P-site, mitochondrial inter-membrane space side or periplasmic side in 
prokaryotes).  The Qi site, where Q is reduced to QH2, is close to the negative side of the 
membrane (N-site, mitochondrial matrix side or cytoplasmic side in prokaryotes). In 
addition to these three core subunits, the cytochrome bc1 complex also contains varying 
number (one to eight) of non-redox containing subunits, known as supernumerary subunits 
(56). Although the function of these supernumerary subunits is not very clear, Chen et al. 
(57) reported that the complexes containing none or less supernumerary subunits were less 
stable and had lower activity than those with more supernumerary subunits. Therefore, it is 
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possible that the increased enzymatic activity and stability for the mitochondrial 
complexes result from the interactions between core subunits and their neighboring 
supernumerary subunits. In addition, subunit I and II of yeast bc1 complex  have been 
reported to be essential for maintaining the proper conformation of cytochrome b to aid in 
the addition of heme (58,59); subunit VI is involved in manipulating dimer/monomer 
transition (60,61); subunits VII and VIII are essential for assembly of the complex (62); 
subunit IX interacts with the iron-sulfur protein, cytochrome b and cytochrome c1 (63). 
Recently, subunit I and II of plant or bovine bc1 complex have been found to possess the 
mitochondrial processing peptidase activity (64,65).  
  The Catalytic Mechanism of the Cytochrome bc1 Complex: Protonmotive Q-cycle-
-The most favorable mechanism for electron transfer and proton translocation in the 
cytochrome bc1 complex is the “protonmotive Q-cycle”, first proposed by Peter Mitchell 
and later modified by several groups (53,66-69) (see Figure 3). According to the Q-cycle 
mechanism, the Qo site of the cytochrome bc1 oxidizes one QH2 from the membrane Qpool, 
releases two protons, and transfers the two electrons into two different electron acceptor 
chains either in a concerted mechanism (53,70-72) or in a sequential mechanism (73-77). 
In the concerted mechanism, two electrons from QH2 are transferred simultaneously in a 
bifurcated pathway: an electron is transferred to heme bL as soon as the other electron is 
transferred to ISP.  Therefore, no ubisemiquinone at the Qo site is generated (see Fig. 3A). 
In the sequential mechanism, the heme bL is reduced by an intermediate ubisemiquinone 
generated at the Qo site after the first electron is transferred to ISP (see Fig. 3B).  
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Figure 3. The protonmotive Q-cycle mechanism with (A) concerted and (B) 
sequential bifurcated reaction at Qo site in the dimeric cytochrome bc1 complex.  
UHDBT, 5-undecyl-6-hydroxy-4,7-dioxobenzothiazole; ISP, Reske iron-sulfur protein; 
QH2, ubiquinol; Q.-, ubisemiquinone; Q, ubiquinone. Blue and green lines indicate the 
electron transfer between redox centers. The red bars show the sites, at which inhibitors 
block electron transfer within the complex. 
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  In both mechanisms, the electron, which has been transferred to ISP, is then 
transferred to cytochrome c1 and then to cytochrome c (c2 in bacteria). Ultimately, this 
electron reaches a terminal acceptor such as cytochrome c oxidase in mitochondria, or the 
oxidized photochemical reaction center in photosynthetic systems. The other electron from 
QH2 is transferred via the heme bL and heme bH of the cytochrome b to the Qi site, where it 
reduces a Q to a detectable ubisemiquinone (SQ). At this point, the reaction is only half 
complete, with only one of the two electrons from QH2 being transferred to cytochrome c. 
In the second half of the Q-cycle, all steps are repeated: one QH2 is oxidized, one 
cytochrome c is reduced, two protons are deposited into the positive side of the membrane, 
and the heme bH is reduced via the heme bL. At the Qi site, the SQ, which is generated in 
the first half of the Q-cycle, accepts another electron from the heme bH and uptakes two 
protons from the negative side of the membrane to form QH2 to complete one Q-cycle. 
Overall, one complete Q-cycle generates one molecule of oxidized ubiquinone, two 
molecules of reduced cytochrome c, uptakes two protons from the negative side of the 
membrane, and deposits four protons to the positive side of the membrane, as summarized 
in Equation 1. 
QH2 + 2 cytochrome c3+ + 2H+N ⇔ Q + 2 cytochrome c2+ + 4H+P                (1) 
The discovery of two sets of inhibitors that bind specifically to Qo and Qi sites (78) 
is crucial for this Q-cycle mechanism. One set of inhibitors, so called class I inhibitors, 
blocks the oxidation of QH2 and bind at or near the Qo site. Class I inhibitors are further 
divided into three sub-classes (Ia, Ib, and Ic) based on chemical characteristics of the 
inhibitors, and on spectroscopic and biophysical effects of the bL heme and the iron-sulfur 
cluster of ISP upon binding of inhibitors. Class Ia inhibitors typically contain a β-
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methoxyacrylate (MOA) group and are referred to as the MOA inhibitors; they 
presumably block the electron transfer from quinol to ISP, accompanied by a red shift in 
the α and β-bands of the reduced heme bL spectrum. Examples of the class Ia inhibitors 
are myxothiazol, azoxystrobin, famoxadone and methoxyacrylate stilbene (MOAS). Class 
Ib inhibitors possess a chromone ring and are believed to inhibit electron transfer from ISP 
to cyt c1; they generate a pronounced increase in redox potential of ISP and, like class Ia 
inhibitors, also cause a red shift of the reduced heme bL spectrum. Stigmatellin is a 
representative of class Ib inhibitors. Class Ic inhibitors are 2-hydroxy quinone analogues 
such as 5-undecyl-6-hydroxy-4,7-dioxobenzothiazole (UHDBT); they block the electron 
transfer in a similar way as the chromone inhibitors, but cause a smaller positive redox 
potential shift of ISP and have no effect on the spectrum of bL heme. The other set of 
inhibitors, namely class II inhibitors, bind to the Qi site of the enzyme complex blocking 
the ubiquinone reduction. Antimycin and heptyldroxyquinoline-N-oxide (HQNO) belong 
to class II inhibitors (79,80). The chemical structures of these inhibitors are summarized in 
Figure 4. 
Although Q-cycle hypothesis can explain many experimental observations very 
well, the question concerning why the branched electron transfer at the Qo site is under 
kinetic control instead of thermodynamic control is still waiting for an answer. There is no 
QH2 found at the Qo site in the available structures and no ubisemiquinone detected at Qo 
site during the catalysis so far. Thus, the exact nature of QH2 binding at the Qo site is 
unknown and becomes a central issue in understanding the electron transfer and proton 





Figure 4. Chemical structures of some cytochrome bc1 inhibitors. NQNO, 




 Three Dimensional Structure of the Cytochrome bc1 Complex--The Q-cycle 
mechanism is supported by current X-ray structural information, which was obtained 
primarily from crystallographic studies of eukaryotic mitochondrial bc1. The three 
dimensional (3D) structure of bovine heart mitochondrial cytochrome bc1 complex was 
first determined by our group in collaboration with Dr. Deisenhofer’s group at 2.9 Å 
resolution (81). Since then, crystallographic structures of bc1 complexes from chicken (69) 
and yeast (82) have become available. The cytochrome b6f is a complex analogous to the 
cytochrome bc1 complex. Recently, its structure has also been established for the 
thermophilic  cyanobacterium Mastigocladus laminosus (83) and the algae 
Chlamydomonas reinhardtii (83,84), at 3.0 Å and 3.1 Å respectively. In bovine I4122 
crystal structure, the bc1 complex contains 4330 amino acid residues with a total molecular 
mass of 496 kDa. The complex exists as a pear-shaped, intertwined homodimeric, multi-
subunit membrane protein with a maximal diameter of 130 Å and a height of 155 Å (see 
Figure 5). Each monomer contains three catalytic subunits and eight supernumerary 
subunits. The complex can be divided into three regions: matrix, trans-membrane helix, 
and inter-membrane space. More than one-half of the molecular mass is located in the 
matrix region, extending 75 Å from the transmembrane helices.  This region contains 
subunits I, II, VI, part of subunit VII, the C-terminal portion of ISP, and subunit IX. The 
transmembrane (TM) region is about 42 Å thick, consisting of 13 transmembrane helices 
in each monomer, eight belonging to cytochrome b, and one each to cytochrome c1, ISP, 
subunits VII, X and XI. The inter-membrane space region, which extends 38 Å into 
intermembrane space from the membrane surface, houses the functional domains of 








Figure 5. The 3-D structure of the mitochondrial cytochrome bc1 complex from bovine 
heart (69). Colors identifying the subunits are given in the left margin. The top of the 





The cytochrome b subunit has 379 amino acid residues and consists of eight 
membrane-spanning helices named sequentially from A to H with both the N and C 
terminus located in the mitochondrial matrix (79-81,85) (see Figure 6). The eight helices 
are arranged in two helical bundles, one consisting of helices A to E and the other of 
helices F to H. The first helical bundle incorporates the hemes bL and bH that are 
coordinated by conserved histidine residues (His-83 and His-182 for the heme bL, His-97 
and His-196 for the heme bH). Prominent extra-membrane features include the AB, CD, 
DE, and EF loops. The DE loop with no secondary structure element is the only one 
located on the matrix side. The AB loop contains one helix, namely the ab, whereas the 
CD loop includes two helices, cd1 and cd2, in a hairpin-like arrangement, providing a 
“lid” for the Qo site and contributing residues to the docking site in the ISP crater for 
interaction with ISP (see Figure 6). The EF loop (residues 247-288) bridges between the 
two helical bundles as well as takes part in the formation of the ISP interaction site. 
Toward the end of the EF loop, there is a 12-residue helix, named ef, situated in a central 
position inside the Qo pocket. The PEWY motif (270-273 in bovine), conserved in all 
organisms, is found at the beginning of the ef helix. The two helical bundles contact each 
other at the matrix side of the membrane, but diverge towards the inter-membrane space 
side to form the Qo pocket between the bL heme and the 2Fe-2S cluster of ISP (80). The Qi 
pocket of the substrate and inhibitor bound structures were determined and defined by the 
structures of bovine mitochondrial bc1 in the presence or absence of bound substrate 
ubiquinone and with the bound antimycin A (80). Residues from transmembrane helices A 
(Trp-31, Asn-32, Gly-34, Ser-35), D (Ala-193, Met-194, Leu-197, His-201), and E (Tyr-






Figure 6. Ribbon presentation of the cytochrome b subunit in the bovine 
cytochrome bc1 (80). The subunit is oriented with the matrix side at the bottom of the 
figure and the intermembrane space (IMS) on the top. The mitochondrial inner 
membrane (MIM) is roughly delineated with the two parallel lines in brown. The eight 
TM helices are labeled A-H. Four prominent surface loops are labeled as AB, CD, DE, 
and EF. The helices within the surface loops are labeled as ab, cd1, cd2, and ef. Two 
active sites in the cyt b are labeled: one is the ubiquinone reduction site (Qi) and the 
other is the ubiquinol oxidation site (Qo). The two intercalating hemes, bL and bH, are 
rendered as the ball-and-stick models with carbon atoms in yellow, nitrogen in blue, 
oxygen in red, and iron in orange. The [2Fe-2S] cluster from subunit ISP is shown as 
balls with sulfur in yellow and iron in orange.  
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 27); the DE loop (Ser-205, Phe-220); and some atoms from the high-potential heme bH 
form the Qi pocket (80).  
Cytochrome c1 consists of an extramembrane domain in the intermembrane space 
along with a single transmembrane helix. Heme c1 is ligated with residues Cys-37 and 
Cys-40. The carboxy group of one of the propionates of the heme c1 forms a salt bridge 
with Arg-120, while the other propionate of the heme c1 extends toward ISP. A methyl 
group on the porphyrin ring is solvent-exposed, likely near the binding site for cytochrome 
c (56). The exposed heme CD edge of cytochrome c1 on the cytoplasmic surface of the 
membrane is surrounded by acidic residues that could form a docking site for cytochrome 
c (81). Tian et al.(86) found that the acidic residues (Glu-74, Glu-101, Asp-102, Glu-104, 
Asp-109, Glu-162, Glu-163, and Glu-168) on the surface of cytochrome c1 of Rhodobacter 
(R.) sphaeroides cytochrome bc1 complex were involved in binding positively charged 
cytochrome c. These acidic residues on opposite sides of the heme crevice of cytochrome 
c1 direct the diffusion and binding of cytochrome c from the intramembrane space.  
ISP contains a transmembrane helix and a hydrophilic domain in the 
intermembrane space and it can be divided into three domains: the membrane spanning N- 
terminal domain (tail domain, residues 1-62), the flexible linking domain (neck domain, 
residues 63-72), and the soluble C-terminal domain (head domain, residues 73-196) 
(87,88). ISPs extend across the interface between the two monomers, with the 
transmembrane helix in one monomer and the extramembrane domain within the other, 
thus resulting in an intertwining structure.  In ISP, the [2Fe-2S] cluster positions at the tip 
of the head domain, bound by Cys-139, His-141, Cys-158, and His-161 (see Figure 7). A 
comparison of the reported crystal structures has shown that the position of [2Fe-2S]  
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cluster changes in the presence of various Qo site inhibitors (69,79-81,89). These suggest 
that the mobility of the head domain of the ISP occurs during bc1 catalysis.  
By using site-directed mutagenesis in R. sphaeroides bc1, Tian et al.(90) 
demonstrated that increasing the rigidity of the ISP neck region by generating a double-
proline substitution at Ala-46 and Ala-48 (ALA-PLP) or a triple-proline substitution at 
residues 42-44 (ADV-PPP) decreases the activity and increases the activation energy. In 
addition,  formation of a disulfide bond from a pair of cysteines substituted at Ala-42 and 
Val-44 (ADV-CDC) or at Pro-40 and Ala-42 (PSA-CSC), in the neck region of ISP, 
drastically reduces electron transfer activity (91). The activity can be restored by cleavage 
of the disulfide bond through the reduction with β-mercaptoethanol (β-ME). These results 
clearly demonstrated a need for neck flexibility for movement of the head domain of ISP 
during bc1 catalysis. In 2000, Xiao et al. (92) further established the involvement of head 
domain movement of the ISP during bc1 catalysis by generation and characterization of 
mutants with a pair of cysteines substituted (one cysteine each) at the interface between 
cytochrome b and the head domain of ISP in R. sphaeroides bc1. The 
A185C(cytb)/K70C(ISP) mutant bc1 complex spontaneously forms a disulfide bond 
between ISP and cytochrome b. Formation of the disulfide bond is concurrent with the loss 






Figure 7. The ligands for the [2Fe-2S] cluster in ISP. 
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Cytochrome bc1 Complex Functioning as a Dimer--The structural information 
suggests that the cytochrome bc1 complex is functioning as a dimer (81) (see Figure 8). 
This suggestion stems from the following structural data:  
(i) The presence of two non-communicating cavities in the dimeric complex, each 
connecting the Qo pocket of one monomer to the Qi pocket of the other monomer (see Fig. 
8A). This makes it possible for a ubiquinone molecule reduced at the Qi site of one 
monomer to be oxidized at the nearby Qo site of the other monomer without leaving the 
bc1 complex or diffusing into the membrane milieu.  
 (ii) The two ISP subunits span both monomers in an intertwined arrangement such 
that the head domain of ISP in one monomer is physically close to the cytochrome b and 
cytochrome c1 in the 2-fold symmetry-related other monomer (see Fig. 8B).  
 To confirm that the cytochrome bc1 complex exists as a dimer with intertwining 
ISPs not only in crystal but also in solution, two R. sphaeroides mutants expressing bc1 
complexes containing two pairs of cysteine substitutions, one at cytochrome b and the 
head domain of ISP and the other at cytochrome b and the tail domain of ISP,  were 
generated and characterized by Xiao et al. (93).  These mutants are: 
K70C(ISP)/A185C(cytb)//P33C(ISP)/G89C(cytb) and 
K70C(ISP)/A185C(cytb)//N36C(ISP)/G89C(cytb). An adduct protein with an apparent 
molecular mass of 128 kDa containing two cytochrome bs and ISPs was detected on SDS-
PAGE as both mutant complexes were not treated by β-ME. This confirms that the bc1 
complex exists as a dimer with intertwining ISPs.  
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Figure 8. Structural data suggesting the cytochrome bc1 complex functioning as a 
dimer. (A) The presence of two non-communicating cavities, each connecting the Qo 
pocket of one monomer to the Qi pocket of the other monomer. (B) The cross 
interaction between two cytochrome b subunits and two ISP subunits related by a 
molecular 2-fold symmetry. (C) Distance between iron centers of heme and [2Fe-2S] 
cluster.  
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 (iii) The distance of 21 Å between the Fe atoms of the two hemes bL is 
approximately the same as that between heme bL and bH within one monomer (see Fig. 
8C). The short distance between the two hemes bL and the presence of several aromatic 
amino acid residues at the interface of the two cytochrome b proteins has promoted 
investigators to speculate the existence of electron transfer or equilibrating between the 
two hemes bL in the two symmetry-related monomers (72,81,94,95). 
 In 2002, Dr. Trumpower’s group (96) demonstrated that stigmatellin and MOAS, 
two inhibitors that block ubiquinol oxidation at Qo site, inhibit the yeast bc1 complex with 
a stoichiometry of 0.5 per one monomer. These data indicate that one molecule of inhibitor 
is sufficient to fully inhibit the dimeric enzyme and imply anti-cooperative interaction 
between the ubiquinol oxidation sites in the dimer. 
 To investigate the interaction between monomers of dimeric cytochrome bc1 
complex, Covian et al. (94) analyzed the pre-steady and steady state activities of the 
isolated yeast bc1 complex in the presence of antimycin at pH 8.8 for wild type and pH 7.0 
for ISP mutant Y185F. The redox potential of ISP in this mutant has value of 215 mV at 
pH 7.0, almost the same as that of the ISP in wild type at pH 8.8. At pH 8.8, the redox 
potential of wild type ISP is about 70 mV lower than that of cytochrome c1. Under these 
conditions, the first turnover of ubiquinol oxidation can be observable in cytochrome c1 
reduction. The amount of cytochrome c1 reduced by several equivalents of decyl-ubiquinol 
in the presence of antimycin is corresponded to only half of that present in the bc1 
complex. Similar experiments in the presence of several equivalents of cytochrome c also 
showed only half of the bc1 complex participating in quinol oxidation. The extent of 
cytochrome b reduced corresponded to two bH hemes undergoing reduction through one 
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Qo site per dimer, indicating electron transfer between the two cytochrome b subunits. The 
stimulation of steady state catalysis by low concentrations of antimycin requires both 
monomers to use only one Qi for Q reduction (94). These suggest that a second turnover 
through the only active Qo in the dimer reduced the bH heme in the adjacent monomer by 
hemes bL to bL transfer.  
 Recently, it was reported that replacing one pair of the aromatic residues located 
between the two bL hemes with alanine in R. sphaeroides cytochrome b decreased slightly 
the steady state activity and increased the production of superoxide radicals at Qo site 
several-fold (97). These indicate that this mutation interferes with electron transfer 
between the two hemes bL in the dimeric bc1 complex. The details will be presented in 
Chapter III of this thesis.  
 Most recently, Covian and Trumpower (95) analyzed the pre-steady state kinetics 
of reduction of cytochrome b by ubiquinol in the presence of variable concentrations of 
antimycin. The results demonstrated that electron equilibration between cytochrome b 
subunits through the bL hemes of the dimeric bc1 complex is the only model consistent 
with the experimental data, i.e., electron equilibration must occur following the route QH2 
(monomer A)→ bH (monomer A)→ bL (monomer A) → bL (monomer B) → bH (monomer 
B) → Q (monomer B).  
 All of these results show that the dimeric structure of the bc1 complex not only has 
a structural role in stabilizing this multisubunit enzyme but also is an essential part of its 
energy conserving mechanism. The possible function of the inter-monomer electron 
communication is to use the stabilization of SQ at the Qi site to maintain the bH hemes in 
the oxidized state, ensuring a maximal rate of QH2 oxidation at the Qo site (72,95). 
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Production of Superoxide Radicals by the Cytochrome bc1 Complex--Respiration 
is linked to the generation of reactive oxygen species, which have been implicated in the 
aging process as well as in a variety of pathological conditions (98,99). Mitochondria are 
the major cellular source of reactive oxygen free radicals (100,101). The superoxide 
radical (O2.-) is the first species in the univalent pathway of oxygen reduction. Two sites of 
the electron transfer chain were identified to be responsible for O2.- generation in 
mitochondria (102). One is located in complex I. At this site, O2.- is probably produced 
through autoxidation of the flavin semiquinone of NADH dehydrogenase (103). The other 
site is located in cytochrome bc1 complex (103).   
During electron transfer through cytochrome bc1 complex, the second electron of 
QH2 can shift from the low potential chain of the Q cycle electron transfer pathway and 
react with molecular oxygen to produce O2.-. The electron leakage site is thought to be 
located at the ubisemiquinone of the Qo site or reduced cytochrome bL (69,97,104-108). 
The amount of electron leakage is believed to be proportional to the concentration of 
reduced cytochrome bL or ubisemiquinone at the Qo site (97).   
 Conveniently, the rate of O2.- production is measured by the superoxide dismutase 
(SOD)-sensitive reduction of cytochrome c (106-108). By this method, the rate of O2.- 
production by the cytochrome bc1 complex can be determined by measuring the decrease 
in rate of cytochrome c reduction in the presence of superoxide dismutase under conditions 
of continuous turnover of the bc1 complex (106-108). However, its relatively low 
sensitivity compromises the accuracy of this method.   
 An alternative method to measure O2.- formation is to follow the 
chemiluminescence of the methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazol [1,2-
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α]pyrazin-3-one hydrochloride (MCLA)- O2.- adduct (69,109).  This MCLA 
chemiluminescence method is 95 times more sensitive than the cytochrome c reduction 
method (110).  During continuing turnover of the bc1 complex (in the presence of 
ubiquinol and cytochrome c), a high background rate of O2.- production resulting from the 
non-enzymatic oxidation of ubiquinol by cytochrome c makes it difficult to 
unambiguously compare rates of O2.- generation in complement and mutant complexes.  
To overcome this difficulty, the chemiluminescence of the MCLA-O2.- adduct during a 
single turnover of bc1 complex is measured using the Applied Photophysics stopped-flow 
reaction analyzer SX.18 MV (97). By leaving the excitation light source off, the 
chemiluminescence of MCLA-O2.-, generated when cytochrome bc1 complex is mixed 
with ubiquinol and MCLA, is registered in light emission.  Since the system contains no 
cytochrome c, chemiluminescence of MCLA-O2.-, resulting from non-enzymatic oxidation 
of ubiquinol by cytochrome c, is eliminated.  This method enables us to accurately 
evaluate changes in the rate of O2.- generation by various bc1 complexes.   
The Cytochrome bc1 Complex from R. sphaeroides--R. sphaeroides has been used 
in our group as a model system to successfully study mitochondrial cytochrome bc1 
complex for a number of years (57,90-93,97,111,112). This organism can be grown 
aerobically, or anaerobically in the dark in the presence of electron acceptors (DMSO), or 
photosynthetically (113). The bc1 complex has a dual role in R. sphaeroides. When the 
cells are grown photosynthetically, the bc1 complex is present in the intracytoplasmic 
membrane (ICM) and is a critical component of the cyclic electron transport system (see 
Fig. 9A). When the cells are grown in the dark in the presence of oxygen, the same bc1 
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complex is a necessary component of the cytochrome c2-dependent respiratory chain (see 
Fig. 9B, left).  
A very important feature and advantage of R. sphaeroides as a model for bc1 
complex study is that the bc1 complex is not essential for its aerobic growth, since the 
electron from ubiquinol can be transferred to oxygen via a quinol oxidase as an alternative 
electron transfer pathway (see Fig. 9B, right). Therefore, R. sphaeroides mutants with 
severely defective bc1 complexes are still able to survive and grow aerobically using the 
quinol oxidase. However, for preparation of bc1 complex, the bacteria are grown under 
“semi-aerobic dark” conditions in order to have ICM where most of the photosynthetic 
machinery of R. sphaeroides is located (114-116). ICM can be analyzed by biophysical 
and biochemical methods to assess the basis of the defect.  
  Bacteria are much easier to handle experimentally than animals, plants and even 
unicellular eukaryote like yeast, especially for mutagenesis studies. Since R. sphaeroides 
bc1 complex is believed similar in its structure and function as the much more complicated 
complex from mitochondria (53), the mutagenesis results from the bacteria can be applied 
to the mitochondrial complex. Efficient molecular engineering protocols for R. 
sphaeroides bc1 complex are well established, and the genes of all its subunits have been 
cloned and sequenced (113,117). 
Tian et al. (90) tagged the R. sphaeroides bc1 complexes with six consecutive 
histidine residues on the c-terminus of the cytochrome c1 subunits, which greatly 
facilitated the purification of the bc1 complexes from cells using the nickel-nitrilotriacetic 
acid (Ni-NTA) agarose column. The purity, activity and cytochrome content of these  
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Figure 9. Electron-transport system of R. sphaeroides involved in anaerobic 
photosynthesis (A), cytochrome c2-dependent aerobic respiration (B, left), and quinol 
oxidase-dependent aerobic respiration (B, right). Enzymes are indicated by boxes. 
Abbreviations: hν, light; Q-pool, ubiquinone pool; cytochrome c oxidase, aa3- and cbb3-
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histidine-tagged bc1 complexes are similar to those of the un-tagged ones. Such genetic 
system has been used extensively to study site-directed mutants and proven to be 
extremely valuable for our knowledge of the cytochrome bc1 complexes (90-93,97,118-
123). 
Extra Fragments of Cytochrome bc1 Complex from R. sphaeroides--The core 
subunits in bacterial complexes are generally bigger than their counter parts in the 
mitochondrial complexes. Sequence alignment of bacterial cytochrome b, cytochrome c1, 
and ISP with their counterparts in the mitochondrial complexes reveals four extra 
fragments in bacterial cytochrome b, and one each in cytochrome c1 and ISP (111). In the 
structure model of R. sphaeroides cytochrome bc1 complex, these four extra fragments of 
cytochrome b are located at the N-terminus (residues 2-12, extra fragment 1), the 
connecting loop between helices D and E (residues 232 to 239, extra fragment 2), the 
connecting loop between ef and F (residues 309-326, extra fragment 3) and the C terminus 
(residues 421-445, extra fragment 4). The extra fragment of cytochrome c1 (residues 141-
161) is located at the long loop after helix α-3; and the extra fragment of ISP (residues 96-
107) is located at the near middle portion of the ISP with an α-helical structure. The 
recently available, low resolution X-ray crystal structure of R. capsulatus bc1 complex 
reveals that the positions of these extra fragments are at the same positions as those of R. 
sphaeroides (88). Unfortunately, the diffraction densities at these fragments are very poor 
and no detailed structural information can be revealed.   
Are these extra fragments required for bc1 complex? One effective way to answer 
this question is by site-directed mutagenesis of residues in these extra fragments followed 
by stability and functional assay of mutant complexes. By using this approach, the 
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cytochrome c1 extra fragment and the N-terminus extra fragment of cytochrome b from R. 
sphaeroides are found to be nonessential. The ISP extra fragment is required for structural 
stability of ISP in the complex (124), and the C-terminus extra fragment of cytochrome b 
(residues 421-445) is essential for maintaining structural integrity of the complex (125). 
However, the knowledge of the role of the second and third extra fragments of cytochrome 
b in R. sphaeroides bc1 complex is still lacking.   
As a continuous work, the role of the third extra fragment (residues 309 to 326) of 
R. sphaeroides cytochrome b, is studied in Chapter IV of this thesis (see Figure 10). This 
extra fragment is located between the ef amphipathic helix and the transmembrane helix F, 







Figure10. Partial sequence comparison in an extra fragment (resides 309-326) of 
various cytochrome bs. Sequence alignment of cytochrome b in bacterial complexes with 
their counterparts in mitochondrial complexes reveals four extra fragments in bacterial 
cytochrome b. They are indicated in red lines at the top of the figure. The abbreviations 
used are: RS, Rhodobacter sphaeroides; RC, Rhodobacter capsulatus; Pd, Paracoccus 
denitrificans; Bf, beef; Yt, yeast; Bj, Bradyrhizobium japonicum. 
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THE UBIQUINONE-BINDING SITE IN NADH:UBIQUINONE 
OXIDOREDUCTASE FROM ESCHERICHIA COLI 
 
Abstract 
 An azido-ubiquinone derivative, 3-azido-2-methyl-5-methoxy[3H]-6-decyl-1,4-
benzoquinone ([3H]azido-Q) was used to study the ubiquinone-protein interaction and to 
identify the ubiquinone-binding site in E. coli NADH:ubiquinone oxidoreductase 
(complex I).  The purified complex I showed no loss of activity after incubation with a 20-
fold molar excess of [3H]azido-Q in the dark.  Illumination of the incubated sample with 
long wavelength UV light for 10 min at 0 °C caused a 40 % decrease of 
NADH:ubiquinone oxidoreductase activity.  Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis of the complex labeled with [3H]azido-Q followed by analysis of the 
radioactivity distribution among the subunits revealed that subunit NuoM was heavily 
labeled, suggesting that this protein houses the Q-binding site.  When the [3H]-azido-Q-
labeled NuoM was purified from the labeled reductase by means of preparative SDS-
PAGE, an azido-Q-linked peptide, with a retention time of 41.4 min, was obtained by high 
performance liquid chromatography of the protease K digest of the labeled subunit.  This 
peptide had a partial N-terminal amino acid sequence of NH2-VMLIAILALV-, which 
45 
corresponds to amino acid residues 184-193 of NuoM.  The secondary structure prediction 
of NuoM using the Toppred hydropathy analysis showed that the Q-binding peptide 
overlaps with a proposed Q-binding motif located in the middle of the transmembrane 
helice 5 toward the cytoplasmic side of the membrane.  Using the PHDhtm hydropathy 
plot, the labeled peptide is located in the transmembrane helix 4 toward the periplasmic 
side of the membrane.  
 
Introduction 
The E. coli NADH-Q oxidoreductase catalyzes electron transfer from NADH to 
ubiquinone and concomitantly translocates protons across the membrane to generate a 
membrane potential and proton gradient for ATP synthesis (1, 2). Whereas the 
mitochondrial enzyme contains up to 46 different subunits (3), this bacterial enzyme is 
made up of only 13 subunits encoded by the nuo-genes (4), and thus is used as a model for 
structural and functional studies of mitochondrial complex I.  
The mechanism of electron transfer and its coupling to proton translocation in 
complex I is poorly understood. Ubiquinone is the final electron acceptor in NADH-Q 
oxidoreductase, and may take part in electron recycling and/or proton transport processes.  
Knowledge of ubiquinone binding is essential for mechanistic studies of this complex. To 
unambigously identify the Q-binding site(s) in complex I, we use a photoactivatable azido-
Q derivative, 3-azido-2-methyl-5-methoxy[3H]-6-decyl-1,4-benzoquinone, which has 
partial electron acceptor activity for complex I, to study the Q/protein interaction in E. coli 
complex I. Herein, we report conditions for photoaffinity labeling of complex I with azido-
Q derivatives and a detailed isolation procedure for the Q-binding peptide. 
46 
Experimental Procedures 
Materials--Sodium cholate was obtained from Sigma and re-crystallized from 
methanol. Dodecyl maltoside (DM) was from Anatrace. Insta-Gel liquid scintillation 
mixture was from ICN. Other chemicals were of the highest purity commercially 
available. The ubiquinone derivatives, 2, 3-dimethoxy-5-methyl-6-isoprenoyl-1, 4-
benzoquinone (Q1), 2, 3-dimethoxy-5-methyl-6-(10-bromodecyl)-1, 4-benzoquinone 
(Q0C10Br), 3-azido-2-methyl-5-methoxy- and 3-azido-2-methyl-5-methoxy[3H]-6-decyl-
1,4-benzoquinone (azido-Q and [3H]azido-Q), 5-azido-2, 3-dimethoxy[3H]-6-decyl-1, 4-
benzoquinone (5-azido-Q) were synthesized by methods reported previously (5), and their 
chemical structures are shown in Figure 11. 
Enzyme Preparations and Assays--E. coli complex I was prepared and assayed 
essentially as previously reported (6). Complex I, azido-Q treated or untreated, was mixed 
with asolectin at a ratio of 1:20 (by weight), incubated at 4 °C for 15 min before assaying 
for activity. The reaction mixture (1ml) contained 50 mM Tris-Cl buffer, pH 7.5, 5 mM 
NaN3, 0.15 % dodecyl-maltoside, 100 µM NADH, and 60 µM Q1. The reaction was 
started by addition of an appropriate amount of azido-Q treated- or untreated- complex I. 
The oxidation of NADH was followed by measuring the absorption decrease at 340 nm, 
using a millimolar extinction coefficient of ε340 nm = 6.22 mM-1 cm –1. 
Identification of Endogenous Quinone in E. coli Complex I--Quinones were 
extracted from purified E. coli complex I with hexane as previously reported (7). The 
concentration of quinone was determined by the method of Redfearn (7). A millimolar 
extinction coefficient of 12.25 mM-1cm-1 was used as the difference in absorption of the 






Figure 11. Chemical structures of the ubiquinone derivatives used in this study. 
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matching the retention time of quinone obtained from complex I with those of reference 
quinones, Q2, Q6, Q8, and Q10, in a HPLC system using a Nova-Pak® reverse phase 
column (C18, 3.9 × 150 mm) from Waters, eluting with a linear gradient of methanol, 
from 90 to 100 % (v/v) in 20 ml at a flow rate of 0.8 ml/min. 
Photoaffinity Labeling of E. coli Complex I with [3H]Azido-Q--The dodecyl 
maltoside present in purified complex I was replaced with sodium cholate by repeated 
dilution-concentration using centriprep-30 as previously described (8).  Complex I as 
prepared (specific activity, 0.301 mol NADH oxidized/min/mg protein) was in 50 mM 
NaCl, 0.15 % dodecyl maltoside, 50 mM MES/NaOH, pH 6.0. This complex was diluted 
with 1 % sodium cholate to a protein concentration of 1 mg/ml in 50 mM K+/Na+ 
phosphate buffer, pH 7.5 and concentrated to 10 mg/ml by centrifugation for 30 min at 
3,000 rpm, using a JS-42 rotor in a Beckman centrifuge J6-HC. The concentrated complex 
I was diluted again with the same buffer containing 1 % sodium cholate and concentrated 
again to 10 mg/ml. This process was repeated eight times. The complex (specific activity, 
0.267 mol NADH oxidized/min/mg protein) was then adjusted to a protein concentration 
of 4 mg/ml in the same buffer, containing 1 % of sodium cholate.  300 µl of this solution 
was mixed with 5 µl of [3H]azido-Q (9.0 mM in 95% ethanol) and incubated at 0 °C for 30 
min in the dark. The specific radioactivity of [3H]-azido-Q used was 9.7 × 103 cpm/nmol 
in 95% ethanol and 3.6 × 103 cpm/nmol in the 50 mM K+/Na+ phosphate buffer, pH 7.5, 
containing 1.0 % sodium cholate in the presence of E. coli complex I. This mixture was 
transferred to a 2-mm light path quartz cuvette which was sealed with paraffin film and 
mounted on an illuminating apparatus. This assembly was immersed in ice water in a 
container with a quartz window and illuminated with long wavelength UV light 
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(Spectroline EN-14, 365 nm long wavelength, 23 watts) for 10 minutes at a distance of 4 
cm from the light source. NADH-Q oxidoreductase activity was assayed, after 
reconstitution with asolectin, before and after the illumination. 
To determine the amount of [3H]azido-Q incorporated into complex I, illuminated 
samples were spotted on Whatman filter paper in the dark, and kept in the dark until all the 
desired samples were collected. The paper was then developed with a solvent system of 
chloroform and methanol (2:1, v/v). Under these conditions, proteins were denatured and 
retained on the original spots and non-protein bound [3H]azido-Q moved upward.  After 
the paper was air-dried, the origin spots was cut into small pieces and subjected to liquid 
scintillation counting in a Packard Tri-Carb 1900CA scintillation analyzer. 
Determination of the Distribution of [3H] Radioactivity among the Subunits of E. 
coli Complex I--The illuminated, [3H]-azido-Q treated sample was digested with 1 % SDS 
and 0.4 % β-mercaptoethanol at 37 °C for 2 hrs before being subjected to SDS-PAGE. The 
SDS-polyacrylamide gel was prepared according to Schägger & von Jagow (9) except that 
bisacrylamide was substituted for the cleavable cross-linker, N, N'-diallyltartardiamide 
(DATA). Electrophoresis was run at 30 V for 2 hrs and then at 80 V for another 6 hrs. 
After electrophoresis, the gel was stained and destained (9). Gels were sliced according to 
the stained protein bands. The portion containing no protein was also sliced to the same 
size as that of the protein bands. Gel slices were completely dissolved by incubation in 
0.3 ml of 3 % periodic acid at room temperature for 1 hr. 5 ml of Insta-Gel counting fluid 
was added and radioactivity determined. 
Isolation of [3H]Azido-Q-labeled NuoM--Part of the digest (see above) was 
subjected to preparative SDS-PAGE. A small portion (10 %) of the SDS-digested protein 
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solution was treated with fluorescamine (100 fold molar excess) for 10 min at 37 °C and 
placed in the reference wells, located on both edges and the middle of the gel. The SDS-
PAGE gel and electrophoresis conditions were as described in the preceding section. The 
protein bands were visualized by the UV fluorescence in the reference lanes. The SDS-
PAGE pattern of the fluorescamine-treated sample was identical to that of the untreated 
sample, as established by Coomassie Blue staining. The NuoM protein band was excised 
from the SDS-PAGE gel. The protein was eluted from the combined gel slices with an 
electro-eluter from Bio-Rad. 
Protease K Digestion of [3H]Azido-Q-Labeled NuoM--Purified [3H]azido-Q 
labeled NuoM obtained by electro-elution was subjected to a repeated dilution and 
concentration process using centriprep-30 with a dilution buffer of 30 mM Tris-Cl, pH 7.5, 
to remove SDS. The final protein concentration was about 1 mg/ml, with the SDS 
concentration around 0.5 %. Protein was then digested with protease K at 37 °C for 6 hrs 
using a protease K:NuoM ratio of 1:50 (w/w). 
Isolation of Ubiquinone-binding Peptides--100 µl aliquots of the protease K-
digested NuoM were separated by high performance liquid chromatography (HPLC) on a 
Supelcosil LC-308 column (C8, 5 µm particles, 300 Å pores, 4.6 mm ID, 25 cm length) 
using a gradient formed from 0.1 % trifluoroacetic acid and 90 % acetonitrile containing 
0.1 % trifluoroacetic acid with a flow rate of 0.8 ml/min. 0.8 ml fractions were collected. 
For each fraction the absorbance, from 200 nm to 400 nm, was recorded with a Waters 996 
Diode Array Detector and radioactivity was measured. Peaks with high specific 
radioactivity were collected, dried, and subjected to peptide sequence analysis. 
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Amino Acid Sequence Determination--Amino acid sequence analyses were done at 
the Molecular Biology Resource Facility, Saint Francis Hospital of Tulsa Medical 
Research Institute, University of Oklahoma Health Sciences Center, under the supervision 
of Dr. Ken Jackson. 
Effect of Cofactors on the Labeling--Aliquots of 0.94 nmol NADH-Q 
oxidoreductase from E. coli in 50 mM K+/Na+ phosphate buffer, pH 7.5, containing 1.0 % 
sodium cholate were incubated with [3H]azido-Q (18.7 nmol) for 30 min at 0 0C in the 
dark, then NADH, NAD or ATP (400 µM final concentration) plus 1 mM sodium pyruvate 
were added for activation, and the incubation was continued for 30 min. Residual NADH 
was oxidized by L-lactate dehydrogenase (type II, from rabbit muscles) to NAD shortly 
before photoirradiation as it would quench the UV light responsible for photoactivation of 
[3H]azido-Q. Then, the mixtures were illuminated under UV for 10 min at 0 0C as 
described above. 
 
Results and Discussion 
Preparation of NADH-Q oxidoreductase--NADH-Q oxidoreductase, prepared 
according to the procedure described (6), contains 0.5 moles of bound coenzyme Q-8 
(ubiquinone-40) per mol protein. When this preparation is titrated with exogenous 
Q0C10Br, no Q-binding is observed, suggesting that the vacant Q-binding site(s) are 
masked by the detergent dodecyl maltoside or phospholipids and the binding affinity of 
Q0C10Br is weaker than that of endogenous Q, phospholipid and detergent used. Since the 
binding affinity of azido-Q derivatives to the Q-binding sites of several Q-binding proteins 
was reported to be weaker than that of Q0C10 or Q0C10Br (16, 21-23), study of the 
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Q:protein interaction in NADH-Q oxidoreductase, using azido-Q derivatives, requires 
prior removal of endogenous Q from the complex and an unmasking of the Q-binding 
sites. 
When NADH-Q oxidoreductase is subjected to a repeated dilution-
centrifugation/concentration process described in ‘Experimental Procedures’; endogenous 
Q8 is partially removed (from 0.5 mol/mol down to 0.3 mol/mol protein), and the Q-
binding site is unmasked. That unmasking occurs during detergent exchange is evident 
from the binding of 0.7 mole of exogenous Q0C10Br to one mol of NADH-Q 
oxidoreductase. The binding of exogenous Q0C10Br was determined by titration according 
to the reported method (8). The SDS-PAGE gel electrophoretic pattern of the cholate 
containing NADH-Q oxidoreductase is similar to that of dodecyl maltoside containing 
enzyme except that a protein band with apparent molecular weight of 75 kDa becomes 
more apparent (see Figure 12). This protein band was identified by partial N-terminal 
amino acid sequence analysis as a proteolytic digestion product of subunit NuoG. Since 
sodium cholate replaced NADH-Q oxidoreductase has its Q-binding site unmasked, it is, 
therefore, suitable for use in photoaffinity labeling studies. 
When the purified and cholate-containing NADH-Q oxidoreductase is incubated 
with a 20 fold molar excess of 3-azido-2-methyl-5-methoxy-6-decyl-1, 4-benzoquinone 
(azido-Q) or 5-azido-2, 3-dimethoxy-6-decyl-1, 4-benzoquinone (5-azido-Q) for 30 min at 
0 °C in the dark and then illuminated with long wavelength UV light for 10 min, only the 
azido-Q treated sample shows inactivation and radioactivity uptaken by protein, indicating 







Figure 12. SDS-PAGE patterns of NADH-Q oxidoreductases before and after 
detergent exchange. Lane 1, protein standard; lane 2, purified NADH-Q oxidoreductase 
in dodecyl maltoside; and lane 3, purified NADH-Q oxidoreductase in sodium cholate. 
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This azido-Q derivative was previously used to identify the Q-binding sites in succinate-Q 
oxidoreductases (10-13) and cytochrome bc1 complexes (5) from several sources.  
Azido-Q Concentration-dependent Inactivation of NADH-Q Oxidoreductase--
Figure 13 shows that when NADH-Q oxidoreductase is incubated with various 
concentrations of azido-Q and illuminated, activity decreases as the concentration of 
azido-Q is increased. Maximum inactivation of 40 % is obtained when 20 mol of azido-Q 
per mol of NADH-Q oxidoreductase is used. Inactivation is not due to the inhibition of 
NADH-Q oxidoreductase by photolyzed products of azido-Q, because when azido-Q is 
photolyzed in the absence of NADH-Q oxidoreductase and then mixed with the enzyme, 
no inhibition is observed. Inactivation is also not due to protein damage by UV radiation, 
because when the enzyme alone is illuminated, no activity loss is observed. Since the 
activity of the azido-Q treated NADH-Q oxidoreductase, after illumination, is assayed in 
the presence of excess Q1 (60 µM), the extent of inactivation should be proportional to the 
fraction of the Q-binding sites covalently linked to azido-Q. 
Correlation between [3H]Azido-Q Incorporation and Inactivation of NADH-Q 
Oxidoreductase--To further confirm that the inactivation observed results from covalent 
linkage of azido-Q to protein in the complex, [3H]azido-Q uptake and the extent of 
inactivation were determined for different periods of illumination. As shown in Figure 14, 
when the complex is treated with 20 molar excess of [3H]azido-Q and illuminated for 
different time periods, activity decreases as illumination time increases; maximum 
inactivation (40 %) is reached at 10 min. Moreover, the amount of [3H]azido-Q 
incorporated into protein parallels the extent of inactivation, until the maximum is reached, 







Figure 13. Effect of azido-Q concentration on NADH-Q oxidoreductase activity after 
illumination. Aliquots (0.1 ml) of NADH-Q oxidoreductase, 1 mg/ml, in 50 mM K+/Na+ 
phosphate buffer, pH 7.5, and 1 % sodium cholate were mixed with 2 µl of an alcoholic 
solution containing the indicated concentrations of azido-Q derivative in the dark. After 
incubation at 0 °C for 30 min the samples were illuminated for 10 min at 0 °C. NADH-Q1 
oxidoreductase activity was assayed, before (solid circles) and after (open triangles) 
illumination, after reconstitution with asolectin. 100 % activity is that of untreated NADH-
Q oxidoreductase, which equals 0.301 µmol NADH oxidized per minute per mg protein in 
dodecyl maltoside and 0.267 µmol NADH oxidized per minute per mg protein in sodium 






Figure 14. Effect of illumination time on azido-Q uptake and inactivation of NADH-
Q oxidoreductase. The NADH-Q oxidoreductase, 1 mg/ml, in 50 mM K+/Na+ phosphate 
buffer, pH 7.5 containing 1 % sodium cholate was incubated with [3H]azido-Q in ethanol 
(open circles, open triangles) or ethanol only (solid circles) for 30 min at 0 °C in the dark. 
The samples were then illuminated with long wavelength UV light for the indicated times 
at 0 °C. The determination of activity (open circles, solid circles) and radioactivity (open 
triangles) were performed as described in “Experimental Procedures”. 
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binding site. Although illumination for longer than 10 min causes no further decrease in 
activity, [3H]azido-Q uptake continues, but at a slower rate, indicating that this 
incorporation is due to nonspecific binding of [3H]azido-Q to protein. It should be 
mentioned that a control sample containing the same amount of ethanol, illuminated under 
identical conditions, shows little (<5 %) activity loss over the time periods studied. 
Identification of Q-binding Subunit in NADH-Q Oxidoreductase by Photoaffinity 
labeling with [3H]Azido-Q Derivatives--Since the uptake of [3H]azido-Q derivative by 
NADH-Q oxidoreductase upon illumination is correlated to the enzymatic inactivation, it 
is reasonable to assume that the azido-Q derivative is bound specifically to the Q-binding 
site(s). Thus, the distribution of the covalently bound azido-Q among subunits of NADH-
Q oxidoreductase after SDS-PAGE indicates the specific Q-binding protein in this enzyme 
complex. Figure 15 shows the 3H-radioactivity distribution among subunits of NADH-Q 
oxidoreductase. The advantage of using the acrylamide/DATA gel system, rather than the 
commonly used acrylamide/bisacrylamide system is that the gel slices can be completely 
dissolved in 3 % periodic acid and this solution can be used directly for radioactivity 
determination. The acrylamide/DATA gel system has been used to identify Q-binding 
proteins in a bacterial reaction center (14) and in mitochondrial ubiquinol-cytochrome c 
reductase (5). The electrophoretic pattern of illuminated, azido-Q treated NADH-Q 
oxidoreductase obtained with the acrylamide/DATA gel system is similar to that obtained 
from the acrylamide/bisacrylamide gel system; 11 major protein bands are observed in 
each (by Coomassie Blue staining). Radioactivity is found in the protein band 5, 
suggesting that this subunit provides the Q-binding site. No radioactivity is found in slices 






Figure 15. [3H ]Radioactivity distribution among subunits of NADH-Q 
oxidoreductase. Purified NADH-Q oxidoreductase was treated with a 20-fold molar 
excess of [3H]azido-Q in the dark for 30 min, and illuminated for 10 min at 0 °C, and 
digested with 1 % SDS and 0.4 % β-mercaptoethanol at 37 °C for 2 hrs before being 
applied to a SDS-PAGE gel. The electrophoretic conditions are described in 
“Experimental Procedures.” Protein bands were visualized by Coomassie Brilliant Blue, 
after staining and destaining, and sliced. The portion containing no protein was also sliced, 
to the same size as that of the protein bands. The gel slices were dissolved with 3 % 
periodic acid and mixed with 5 ml of Insta-Gel, and the radioactivity was determined. 
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cholate. Since the amount of radioactivity in band 5 was directly proportional to the extent 
of inactivation of the oxidoreductase, participation of this protein in Q-binding is 
established. 
This radioactive protein band in SDS-PAGE of the illuminated [3H]azido-Q-treated 
NADH-Q oxidoreductase is identified as NuoM, based on the identification of two NuoM 
peptides in the protease K digest of the labeled protein. Peptide peaks with retention times 
of 29.9 min and 45.8 min obtained from HPLC separation of protease K digested labeled 
protein have the partial N-terminal amino acid sequence of NH2-SAAGLFI- and NH2-
LPDAH- corresponding to residues 351 to 357 and 244 to 248 of NuoM subunit, 
respectively. 
The identification of NuoM as the ubiquinone binding subunit of NADH-Q 
oxidoreductase is consistent with the report (15) that human complex I lacking the 
mtDNA-encoded subunit ND4, due to a frameshift mutation in the gene, has no NADH:Q1 
oxidoreductase activity but with normal NADH:Fe(CN)6 oxidoreductase activity. ND4 of 
human complex I is the counterpart of NuoM of E coli enzyme (16). 
Isolation and Characterization of Ubiquinone-binding Peptides of NuoM--In order 
to identify the Q-binding domain in NuoM through isolation and sequencing of an azido-
Q-linked peptide, it is absolutely necessary that the isolated azido-Q labeled NuoM has to 
be free from contamination with unbound azido-Q and completely susceptible to 
proteolytic enzyme digestion. [3H]Azido-Q-labeled NuoM was isolated from illuminated, 
[3H]azido-Q-treated NADH-Q oxidoreductase by a procedure involving preparative SDS-
PAGE, electrophoretic elution, and repeated dilution/concentration with centriprep-30. 
The SDS-PAGE step removes non-protein-bound azido-Q adducts. The SDS concentration 
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in the final purification step is about 0.5 %, while the concentration of [3H]azido-Q labeled 
NuoM is about 1 mg/ml. Isolated [3H]azido-Q-labeled NuoM shows only one band, in 
SDS-PAGE, which corresponds to the fifth subunit of NADH-Q oxidoreductase (data not 
shown). About 40 % of the NuoM protein present in NADH-Q oxidoreductase is 
recovered in the final purification step, assuming a molecular mass of 535 kDa for the E. 
coli NADH-Q oxidoreductase and that it contains 1 mol of NuoM/mol enzyme. This low 
yield of NuoM is probably due to our very small slicing of the NuoM band, in order to 
avoid contamination with neighboring proteins.  
When SDS present in purified [3H]azido-Q-labeled NuoM was removed by the 
commonly used cold acetone precipitation method, the resulting protein is highly 
aggregated and resistant to proteolytic enzyme digestion. Inclusion of 0.1 % SDS and 2 M 
urea in the digestion mixture does not increase proteolysis. Since the SDS-free, [3H]azido-
Q labeled NuoM is not digested by proteolytic enzymes, we needed a protease that is 
active when SDS concentration is higher than 0.5 %. Since of the commercially available 
proteolytic enzymes only protease K was reported to be active in 0.5 % SDS and 1 M urea, 
isolated [3H]azido-Q labeled NuoM was subjected to protease K digestion at 37 °C using a 
protease K:NuoM ratio of 1:50 (w/w). To obtain the optimal digestion time 100 µl aliquots 
were withdrawn from the digestion mixture at different time intervals, subjected to HPLC 
separation, and analyzed for peptide patterns and radioactivity recovery on HPLC 
chromatograms. At 37 °C, a 6 hrs digestion time was found to be optimal. Figure 16 shows 
the 3H radioactivity distribution on HPLC chromatogram of [3H]azido-Q-labeled NuoM 
digested with protease K. Most of the radioactivity was found in one fraction with the 
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retention time of 41.4 min (P42). The radioactivity recovery is about 72 % based on what 
was applied to the HPLC column. 
The partial NH2-teminal amino acid sequence of P42 was found to be NH2-
VMLIAILALV-, corresponding to amino acid residues 184-193 of NuoM. By mass 
spectral analysis, we determined the size of this Q-binding peptide to be 2906.4, 
suggesting that the Q-labeled peptide is composed of 23 amino acid residues, from V184 
to N206.In the Toppred hydropathy analysis (17) of NuoM, this Q-binding peptide 
overlaps with the proposed Q-binding motif (L-X3-H-X3-T/S) (18) located in the middle of 
transmembrane helix 5 toward the cytoplasmic side of the membrane (see Figure 17a).  If 
the PHDhtm hydropathy plot (19) is used (see Figure 17b), the Q-binding peptide is 
located in transmembrane helix 4, toward the periplasmic side of the membrane. It should 
be noted that the Q-binding domain identified in this study differs from that identified for 
rotenone binding in NADH-Q oxidoreductase (20, 21). Although only one Q-binding 
peptide is identified in the this study, one cannot rule out the possibility of more than one 
Q-binding site, because inhibition of the azido-Q treated sample is less than 50 % and a 
substantial amount of endogenous Q8 (0.3 mole per mole protein) remains in the Q-
deficient complex. The residual Q8 would render a portion of the Q-binding site or a 
different Q-binding site inaccessible to azido-Q. 
Recently, Nakumara-Ogiso et al. (22) have identified subunit ND5 (NuoL in 
E.coli) as Q-binding site based on the photoaffinity labeling study of submitochondrial 
particles using analogue of fenpyroximate, a specific inhibitor of complex I. Although the 
assumption that this inhibitor binds directly at the Q-binding site is difficult to establish, 






Figure 16. [3H] Radioactivity distribution in an HPLC chromatogram of a protease 
K-digest of [3H]azido-Q- labeled NuoM protein. The labeled protein (1 mg/ml, 1 × 105 








Figure 17. Putative Q-binding domain in the proposed structure of NuoM. The 
proposed secondary structure of NuoM of E. coli NADH-Q oxidoreductase was 
constructed from on the hydropathy plots of its amino acid sequence using Toppred 
hydropathy analysis (a) and the program of PHD (b). The shaded area indicates the Q-
binding peptide identified in this report. The Q-binding motif (L-X3-H-X3-T) in complex I 
predicted by Fisher and Rich (18) is shown by squares. 
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identification of ND5 as one of the subunits possibly involved in quinone binding is very 
interesting as ND5 also contains a Q-binding motif, A-X3-H-X2-T. ND5 is composed of  
14 transmembrane helices in the Toppred hydropathy plot, the Q-binding motif is located 
at the connecting loop of transmembrane helices 8 and 9 on the periplasmic side of the 
membrane. In the similar plot, Q-binding motif of NuoM, L-X3-H-X3-T, is located the end 
of transmembrane helix 5 toward the cytoplasmic side of the membrane. This would 
indicate that the Q-binding site in ND5 is not a part of the Q-binding site loacted in ND4.  
On the other hand, if PHDhtm hydropathy plots are compared then the Q-binding motif in 
ND5 could be a part of Q-binding site in ND4, as the motif of ND5 is located on the end of 
the transmembrane helix 9 toward periplasmic side of the membrane, which is spatially 
similar to Q-binding motif of NuoM locating at the connecting loop of transmembrane 
helices 4 and 5 on the periplasmic side of the membrane. In this context it is noteworthy to 
mention that ND4 and ND5 have evolved from a common ancestor (23) and might share 
related but not identical functions in NADH-Q oxidoreductase (24). 
Effects of Cofactors on the Labeling of NuoM by [3H]azido-Q--Table 3 shows the 
effects of 400 µM of NADH, NAD and ATP on [3H]azido-Q labeling of NuoM. NAD and 
ATP had essentially no effect, which is consistent with the data recently reported by 
Nakamaru-Ogiso et al. (22) during photoaffinity labeling of inhibitor/quinone probes in 
complex I when isolated submitochondrial particles were used. [3H]azido-Q labeling of 
NuoM subunit was not influenced by prior NADH incubation, even though NADH has 
been reported to stimulate the labeling of inhibitor/quinone probes in mitochondrial 
complex I (22, 25). Similar data was also obtained with a [3H]pyridaben analogue labeling 





Table 3: Effects of cofactors on the labeling of NuoM by [3H]azido-Q 
Relative amount of radioactivity 
incorporated by protein Additions 
(%) 
Control 100a 
       NADH (400 mM) 99 
    NAD (400 mM) 98 
 ATP (400 mM) 99 
a 100% indicates 5,626 cpm/nmol of protein. 
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 Activation of NADH-Q oxidoreductase by NADH has solely been demonstrated for the 
mitochondrial but not for the bacterial enzyme. The E. coli NADH-Q oxidoreductase 
shows no activity with NADPH as substrate and addition of NADPH has consequently no 
effect on the labeling of NuoM. These data suggest that activation of NADH-Q 
oxidoreductase by NADH has an effect on the binding of inhibitors, most likely due to 
conformational changes, but that binding of quinone itself is not influenced. This is 
another indication that at least the Q-binding site identified in this report is not identical to 
the inhibitor binding sites described in the literature. 
Effects of Inhibitors of E. coli NADH-Q oxidoreductase on [3H]azido-Q labeling of 
NuoM--We also examined the effects of various complex I inhibitors on the labeling with 
[3H]azido-Q (see Figure 18). Rotenone was excluded in this series as it has only a very 
minor effect on the activity of the E. coli NADH-Q oxidoreductase (26). A 20-35% 
decrease in labeling of NuoM with [3H]azido-Q was observed when dihydrocapsaicin (10 
nmol/mg protein), pyridaben (1.0 nmol/mg protein), rolliniastatin-1 (0.2 nmol/mg protein), 
piericidin A (0.6 nmol/mg protein) and fenazaquin (1.0 nmol/mg protein) were used.  At 
the concentrations given each inhibitor shows complete inhibition of NADH 
oxidoreductase activity. Similar phenomena were reported with the highly potent and 
specific inhibitor trifluromethyldiazirinyl[3H]pyridaben labeling of the PSST subunit in 
isolated submitochondrial particles (25). Again, these results suggest that the binding sites 
of these inhibitors may not overlap with that of [3H]azido-Q. The minor effect observed 
upon addition of inhibitors is probably due to a conformational change in NADH-Q 
oxidoreductase induced by binding of inhibitors. Alternatively, the minor effect of 
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inhibitors on [3H]azido-Q labeling of NuoM could be explained by a partially overlapping  
a common binding site of inhibitors with [3H]azido-Q binding site. 
The location of the Q-binding site(s) in complex I is still under debate. So far, 
inhibitor labeling was set out for the identification of this site(s). Using various, 
structurally different inhibitors ND5 (NuoL) (31), PSST (NuoB) (27), and ND1 (NuoH) 
(21) have been indicated as the possible candidates representing this site. The 49 kDa 
(NuoD) was proposed to be involved in Q-binding due to inhibitor resistance conferred by 
a point mutation in this subunit (28). Thus, the Q-binding site is most likely located at the 
interface of the hydrophilic and hydrophobic part of the enzyme. NuoB, D, H, and either 
NuoM or NuoL seem to be in close spatial proximity as all these subunits are part of the 
evolutionary conserved hydrogenase module complex (29). As NuoM and L are related to 
each other it is hard to decide which of these two subunits is part of the hydrogenase 
module (29). Electron microscopic experiments indicate that NuoL is located at a distant 
position to NuoM (30). Therefore, it is most likely that NuoB, D, H, and NuoM are 
involved in building the Q-binding site of the complex. Contrary to the experiments 
carried out so far, we used a labeled quinone derivative for direct identification of ND4 
(NuoM) as Q-binding site. This fits well with the proposed proximity of this subunit with 
NuoB, D, and H (30). Because the binding of the various inhibitors is affected by the 
presence of other inhibitors it was concluded that these binding sites partially overlap (31). 
Here, we have shown that the binding of [3H]azido-Q is not influenced by addition of 







Figure 18. Effects of various complex I inhibitors on [3H] azido-Q labeling of NuoM. 
NADH-Q oxidoreductase from E. coli (0.94 nmol protein in 50 mM K+/Na+ phosphate 
buffer, pH 7.5, containing 1.0 % sodium cholate) were treated with each inhibitor for 30 
min on ice and incubated with [3H]azido-Q (18.7 nmol) for 30 min at 0 oC in the dark.  
Then, the mixture was illuminated under UV for 10 min at 0 0C as described in 
“Experimental Procedures”. Each calibration bar at the bottom designates 5.63 x 103 
cpm/nmol of protein. 
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EVIDENCE FOR ELECTRON EQUILIBRIUM BETWEEN THE TWO HEMES bL 
IN THE DIMERIC CYTOCHROME bc1 COMPLEX  
 
Abstract 
The structural analysis of the dimeric mitochondrial cytochrome bc1 complex 
suggests that electron transfer between inter-monomer hemes bL-bL may occur during bc1 
catalysis. Such electron transfer may be facilitated by the aromatic pairs present between 
the two bL hemes in the two symmetry-related monomers. To test this hypothesis, R. 
sphaeroides mutants expressing His6-tagged bc1 complexes with mutations at three 
aromatic residues (F195, Y199, and F203), located between two bL hemes, were generated 
and characterized. All three mutants grew photosynthetically at a rate comparable to that 
of wild-type cells. The bc1 complexes prepared from mutants F195A, Y199A and F203A 
have, respectively, 78%, 100%, and 100% of ubiquinol-cytochrome c reductase activity 
found in the wild-type complex. Replacing the F195 of cytochrome b with Y, H, or W 
results in mutant complexes (F195Y, F195H, or F195W) having the same ubiquinol-
cytochrome c reductase activity as the wild-type. These results indicate that the aromatic 
group at position195 of cytochrome b is involved in electron transfer reactions of the bc1 
complex. The rate of superoxide anion (O2-.) generation, measured by the 
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chemiluminescence of 2-methyl-6-(p-methoxyphenyl)-3, 7-dihydroimidazo[1,2-α]pyrazin-
3-one hydrochloride (MCLA)-O2-. adduct during oxidation of ubiquinol, is 3 times higher 
in the F195A complex than in the wild-type or mutant complexes Y199A or F203A. This 
supports the idea that the interruption of electron transfer between the two bL hemes 
enhances electron leakage to oxygen and thus decreases the ubiquinol-cytochrome c 
reductase activity.  
 
Introduction 
The crystal of mitochondrial cytochrome bc1 complex shows the distance between 
the Fe atoms of the two hemes bL is only 21 Å, which is approximately the same as that 
between heme bL and bH in one monomer (1-4) (see Figure 19). The short distance 
between the two hemes bL and the presence of several aromatic amino acid residues at the 
interface of the two cytochrome b proteins has promoted investigators to speculate the 
existence of electron transfer or equilibrating between the two hemes bL (5-7). However, 
evidence for inter-monomer bL-bL electron transfer during bc1 catalysis is still missing, due 
to the lack of a suitable assay method.   
It has been reported that during electron transfer through the bc1 complex, 
superoxide anion (O2.-) is produced (8-14). This results from a leakage of the second 
electron of ubiquinol, from the "low-potential chain" of the Q cycle electron transfer 
pathway, to interact with molecular oxygen. The electron-leaking site is thought to be 
located at the reduced cytochrome b566 (bL) or ubisemiquinone of the Qo site. The amount 






Figure19. Distances between redox centers in bovine dimeric cytochrome bc1 
complex. All distance measurements are made with native mitochondrial bc1 complex, 
refined to 2.4 Å resolution. The center to center distances are indicated by red arrowed 
lines and are as labeled; the edge to edge distances of are shown with black arrowed lines 
and are as labeled. 
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the concentrations of reduced cytochrome bL or ubisemiquinone at the Qo site. Thus, if the 
inter-monomer bL-bL electron transfer is interrupted, one should see an increase in the rate 
of O2.- generation because electrons that normally shuttle between the two bL hemes will 
accumulate at the bL heme of one monomer, thus enhancing the chance for leakage and 
reaction with oxygen.  
In the 3-D structure of mitochondrial bc1 complex, several pairs of aromatic 
residues are located at the dimer interface between the two hemes bL (1). These aromatic 
pairs may facilitate the inter-monomer heme bL→ bL electron transfer. If this is indeed the 
case the existence of inter-monomer heme bL-bL electron transfer in the bc1 complex can 
be revealed by comparing the rates of O2.- generation by the wild-type bc1 complex with 
those of mutant complexes having these aromatic pairs replaced with non-aromatic 
residues. An increase in O2.- generation, as a result of increasing the concentration of 
reduced bL or ubisemiquinone at the Qo site, by the mutant bc1 complex, would indicate 
inter-monomer heme bL-bL electron transfer, involving aromatic amino acid residues.  
 Herein we report procedures for generating R. sphaeroides mutants expressing 
His6-tagged bc1 complexes with mutations at three highly conserved aromatic residues 
(F195, Y199, and F203) located between the two bL hemes of the dimeric complex. The 
rate of superoxide anion generation, the effect of oxygen on the activity and the EPR 
characteristics of the cytochromes bL and bH in purified complexes from wild type and 
mutant strains are examined and compared.  
 
Experimental Procedures 
Materials--Cytochrome c (horse heart, type III), hypoxanthine, and superoxide 
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dismutase (SOD), and xanthine oxidase were purchased from Sigma Chemical Co. 
Dodecylmaltoside (DM) and octylglucoside (OG) were from Anatrace. Nickel 
nitrilotriacetic acid (Ni-NTA) gel and a Qiaprep spin Miniprep kit were from Qiagen. 2-
Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazol [1,2-α]pyrazin-3-one, hydrochloride 
(MCLA) was from Molecular Probes, Inc. 2,3-Dimethoxy-5-methyl-6-(10-bromodecyl)-
1,4-benzoquinol (Q0C10BrH2) was prepared in our laboratory as previously reported (15). 
All other chemicals were of the highest purity commercially available.  
   Generation of R. sphaeroides Strains Expressing the His6-Tagged Cytochrome bc1 
Complexes with Mutations of Aromatic Residues Located at the Dimer Interface between 
Two Hemes bL--Mutations were constructed by the Quick Change site-directed 
mutagenesis kit from Stratagene using a supercoiled double-stranded pGEM7Zf(+)-fbcFB 
as template and a forward and a reverse primer for PCR amplification. The pGEM7Zf(+)-
fbcFB plasmid (16) was constructed by ligating the EcoRI-XbaI fragment from 
pSELNB3503 into EcoRI and XbaI sites of the pGEM7Zf(+) plasmid. The primers used 
are given in Table 4. 
 The BstEII-XbaI fragment from the pGEM7Zf(+)-fbcFBm plasmid was ligated 
into the pRKD418-fbcFBKmBXCHQ plasmid to generate the pRKD418-fbcFBmCHQ 
plasmid.   A plate-mating procedure (17) was used to mobilize the pRKD418-fbcFBmCHQ 
plasmid in E. coli S17-1 cells into R. sphaeroides BC17 cells. The presence of engineered 
mutations were confirmed by DNA sequencing of the 962-base pair BstEII-XbaI fragment 
before and after photosynthetic growth of the cells as previously reported (17). DNA 
sequencing and oligonucleotide syntheses were performed by the Recombinant 
DNA/Protein Core Facility at Oklahoma State University.  
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Table 4. Oligonucleotides used for site-directed mutagenesis (F and R in the parentheses 






























































a The underlined bases correspond to the genetic codes for the amino acid(s) to be mutated. 
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    Growth of Bacteria--E. coli cells were grown at 37 °C in LB medium (sodium 
chloride, SELECT peptone 140, and SELECT yeast extract, autolyzed low sodium). For 
photosynthetic growth of the plasmid-bearing R. sphaeroides BC17 cells an enriched 
Siström's medium containing 5 mM glutamate and 0.2% casamino acids was used. 
Photosynthetic growth conditions for R. sphaeroides were essentially as described 
previously (17). Cells harboring the mutated cytochrome b gene on the pRKD418-
fbcFBmCHQ plasmid were grown photosynthetically for one or two serial passages to 
minimize any pressure for reversion. The inoculation volumes used for photosynthetic 
cultures were at least 5% of the total volume. Antibiotics were added to the following 
concentrations: ampicillin (125 µg/ml), kanamycin sulfate (30 µg/ml), tetracycline 
(10 µg/ml for E. coli and 1 µg/ml for R. sphaeroides), and trimethoprim (100 µg/ml for 
E. coli and 30 µg/ml for R. sphaeroides). Cells were harvested with centrifugation at 3,500 
x g for 30 min, when the turbidity (OD600nm) of the cell culture reached 2.0. The harvested 
cells were then washed with 20 mM Tris-succinate buffer, pH 7.5, and stored at -20oC. 
About 5 grams of cells were routinely obtained from one liter of culture.  
Enzyme Preparations and Activity Assay--Chromatophores were prepared as 
described previously (18). Frozen R. sphaeroides cells were suspended in 3 ml of 20 mM 
Tris-succinate (pH 7.5 at 4oC) in the presence of 1 mM sodium 
ethylenediamminetetraacetate (EDTA) per gram of cells, and passed twice through French 
press with 1,000 psi to break open the cells. During the suspension, a grain of DNase was 
added to digest the DNA, which will come out during cell’s breakage and cause the tissue 
to be sticky thus giving incomplete solubilization of protein. Additionally, a protease 
inhibitor, phenylmethylsulfinyl fluoride (PMSF) freshly dissolved in dimethylsuloxide 
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(DMSO), was added to the cell suspension with the final concentration of 1 mM before 
passing through the French press, and was added to the same concentration two more 
times after each passage through the French press. The broken cells were centrifuged at 
40,000 x g (19,000 rpm with JA-20 rotor) for 20 min to remove unbroken cells and cell 
debris. The supernatant was then subjected to centrifugation at 220,000 x g (49,000 rpm 
with rotor Ti-50.2 or 60,000 rpm with rotor Ti-70) for 150 min to separate the 
chromatophore fraction from the soluble protein fraction. The precipitate obtained was 
washed with buffer A (50 mM Tris/HCl, pH 8.0 at 4oC, containing 1 mM MgSO4) with 1 
mM PMSF, and centrifuged at 220,000 x g for 90 min to recove the chromatophore in 
precipitate. The resulting chromatophores were suspended in buffer A in the presence of 1 
mM PMSF and 20% glycerol, and stored at -800C, until use. To purify the His6-tagged 
cytochrome bc1 complex, the chromatophore suspensions were thawed and adjusted to a 
cytochrome b concentration of 25 µM with buffer A and 1 mM PMSF. DM solution (10%, 
w/v) was added to the chromatophore suspension to 0.56 mg/nmol of cytochrome b, and 
the mixture was stirred at 4 °C for 30 min. Then NaCl solution (4 M) was added to a final 
concentration of 0.1 M, and the suspension was stirred for 1 h at 4 °C. This mixture was 
centrifuged at 220,000 x g for 90 min. The supernatants were collected and diluted using 
the equivalent volume of BufferA following by passing through the Ni-NTA column 
(100 nmol of cytochrome b/ml of resin) equilibrated with buffer A at 4 °C. The column, 
absorbed with bc1 complexes, was then subjected to a sequence of washings with TN 
buffer, which is 50 mM Tris-Cl (pH 8.0 at 4 °C) and 200 mM NaCl, containing 0.01% 
DM, TN buffer containing 5 mM histidine and 0.01% DM, and TN buffer containing 0.5% 
OG, and TN buffer with 5 mM histidine and 0.5% OG. The pure cytochrome bc1 complex 
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was eluted with TN buffer containing 200 mM histidine and 0.5% OG and concentrated 
using a Centriprep-30 concentrator to a final concentration of 300 µM cytochrome b or 
higher. The purified complex was stored at -80 °C in the presence of 20% glycerol. To 
assay cytochrome bc1 complex activity, chromatophores or purified cytochrome bc1 
complexes were diluted with 50 mM Tris-Cl, pH 8.0, containing 200 mM NaCl and 0.01% 
DM to a final concentration of cytochrome b of 3 µM. Appropriate amounts of the diluted 
samples were added to 1 mL of assay mixture containing 100 mM Na+/K+ phosphate 
buffer, pH 7.4, 300 µM EDTA, 100 µM cytochrome c, and 25 µM Q0C10BrH2. Activities 
were determined by measuring the reduction of cytochrome c (the increase of absorbance 
at 550 nm) in a Shimadzu UV 2101 PC spectrophotometer at 23 0C, using a millimolar 
extinction coefficient of 18.5 for calculation. The non-enzymatic oxidation of Q0C10BrH2, 
determined under the same conditions in the absence of enzyme, was subtracted from the 
assay. To measure bc1 activity in chromatophores, 30 µM potassium cyanide was added to 
the assay mixture to inhibit the trace of cytochrome c oxidase activity.  
To measure the effect of oxygen on bc1 activity, a Thunberg cuvette was used.  
1 ml of assay mixture was placed in the main chamber, and a 10-µl aliquot of enzyme (5-
10 pmol) was in the side arm. The cuvette was evacuated and flushed with argon 5 times.  
The reaction was started by mixing the bc1 complex solution and the assay mixture. 
Measurement of Superoxide Anion Generation--Superoxide anion generation by 
the cytochrome bc1 complex was determined by measuring the chemiluminescence of 
MCLA-O2-. adduct (19), in an Applied Photophysics stopped-flow reaction analyzer 
SX.18MV (Leatherhead, England), by leaving the excitation light off and registering light 
emission (20). Reactions were carried out at 23 °C by mixing 1:1 solutions A and B. 
81 
Solution A contains 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM EDTA, 1 mM KCN, 
1 mM NaN3, 0.1% BSA, 0.01% DM and an appropriate amount of wild-type or mutant bc1 
complex. Solution B was the same as A with bc1 complex being replaced with 50 µM 
Q0C10BrH2 and 4 µM MCLA. O2-.generation is expressed in XO units. One XO unit is 
defined as chemiluminescence (maximum peak height of light intensity) generated by 1 
unit of xanthine oxidase, which equals 2.71 V from an Applied Photophysics stopped-flow 
reaction analyzer SX.18MV, when solution A containing 100 mM Na+/K+ phosphate 
buffer, pH 7.4, 100 µM hypoxanthine, 4 µM MCLA, and 1 mM NaN3 is mixed with 
solution B containing 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM NaN3, and 50 
units/ml of xanthine oxidase.  
Other Biochemical and Biophysical Techniques--Protein concentration was 
determined by the method of Lowry et al. (21). The protein sample was diluted to a 
concentration of 0.1-0.5 mg/ml. To 0.2 ml of the diluted sample, 1 ml of copper-alkali 
solution was added. The copper-alkali solution contained 0.01% of copper sulphate 
(CuSO4⋅5H2O), 0.02% of sodium potassium tartrate, 0.1 M of sodium hydroxide and 2% 
of sodium carbonate. After mixing and incubating for 10 min, 0.05 ml of Folin-
Ciocalteau’s phenol reagent (Sigma F-9252) was added. The absorbance at 550 nm was 
read after 30 min incubation. Bovine serum albumin (BSA) was used as a standard to 
estimate the protein concentration of the sample. The content of cytochrome b was 
determined from the sodium dithionite reduced minus potassium ferricyanide spectrum 
using the extinction coefficient of 28.5 mM-1cm-1 for wavelength pair 560 and 576 nm (22) 
and the content of cytochrome c1 was from the sodium ascorbate reduced minus potassium 
ferricyanide spectrum using 17.5 mM-1cm-1 as the extinction coefficient for wavelength 
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pair 552 and 537 nm (23). SDS-PAGE was performed according to Laemmli (24) using a 
Bio-Rad Mini-Protean dual slab vertical cell. Samples were digested with 10 mM Tris-Cl 
buffer, pH 6.8, containing 1% SDS, and 3% glycerol in the presence of 0.4% β-
mercaptoethanol for 2 h at 37 °C before being subjected to electrophoresis. 
EPR spectra of b cytochromes were recorded at 8.5 K on a Bruker EMX EPR 
spectrometer equipped with an Air Products flow cryostat. The instrument settings are 
detailed in the figure legend. Refined coordinates for the crystal structure of native bovine 
mitochondrial bc1 (25, PDB code 1NTM) were used for distance determination. 
 
Results and Discussion 
Involvement of the F195 of Cytochrome b in Electron Transfer Activity of the 
Cytochrome bc1 Complex--Three aromatic amino acid residues in cytochrome b: F195, 
Y199, and F203, were selected for mutation to test the hypothesis that inter-monomer bL-
bL electron transfer occurs during bc1 catalysis and such electron transfer is facilitated by 
aromatic residues located between the two bL hemes. Alignment of more than 40 
sequences of cytochrome b reveals that F195 is fully conserved except in R. virids (in 
which F is replaced by Y); Y199 is highly conserved although it is replaced by F in many 
cases; and F203 is less conserved, being substituted with M, S, L and W in some species 
(26). The selection of these three residues was based on the three-dimensional structure of 
the four-subunit cytochrome bc1 complex of R. sphaeroides (see Figure 20A) constructed 
by using coordinates from bovine cytochromes b and c1, ISP, and subunit VII (27). The 
distances between the symmetry pairs of aromatic residues F195, Y199, or F203 are 
4.5, 7.7, and 6.8 Å (see Figure 20B), respectively, when measured from edge to edge of 
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the phenyl rings of the amino acid residues. They are, edge to edge, 3.8, 3.7, and 3.3 Å 
apart, respectively, in the corresponding residues in the bovine complex (F179, F183 and 
F187 in bovine). The distances from heme bL to F195, Y199, or F203 are 8.8, 4.9. 10.3 Å, 
respectively, when measured from the iron center to the edges of the aromatic ring of the 
amino acid residues. They are 7.5, 8.6, and 10.2 Å, respectively, in the corresponding 
bovine enzyme. Recently a relative low resolution structure of cytochrome bc1 complex 
from Rhodobacter capsulatus was reported (28). The distances obtained among these 
aromatic amino acids pairs are surprisingly close to those deduced from model of R. 
sphaeroides’ complex.  
 When each of these three aromatic residues was replaced with alanine, the resulting 
mutants (F195A, Y199A, and F203A) grew photosynthetically at a rate comparable to that 
of the complement (wild-type) cells. Chromatophores prepared from these mutants have, 
respectively, 80, 100, and 100% of the bc1 activity found in the complement 
chromatophores (see Table 5). When cytochrome bc1 complexes prepared from these three 
mutant chromatophores were assayed for ubiquinol-cytochrome c reductase activity, the 
Y199A and F203 mutant complexes had the same activity as the complement complex and 
the F195 mutant complex had about 78% (see Table 5). These results indicate that F195 of 
cytochrome b is involved in inter-monomer electron transfer in the dimeric bc1 complex, 












Figure 20. Location of mutated aromatic residues in the structural model of the R. 
sphaeroides bc1 complex. In the upper panel (A), cytochrome b is shown in blue ribbon  in 
one monomer and green in the symmetric monomer, ISP (from the symmetric monomer) 
is in yellow, and cytochrome c1 from the same monomer is in pink. Both subunit IVs, ISP 
(from one monomer) and cytochrome c1 (from the symmetric monomer) are shown in 
turquoise. All hemes are indicated by red sticks. The mutated aromatic residues are 
indicated by blue sticks in cytochrome b in one monomer and green sticks in the 
symmetric monomer. The lower panel (B) shows the residues located on the interface of 
two bL hemes, and mutated to alanine, from different cytochrome b’s. Some peptide 
sequences have been omitted for clarity. The nearest edge to edge distances between 




 Mutants with double and triple alanine substitutions in these three aromatic 
residues of cytochrome b were also generated and characterized. These are:  
F195A/Y199A, F195A/ F203A, Y199A/F203A, and F195A/Y199A/F203A. All but 
theY199A/F203A mutant complex have about 78% of the activity found in the 
complement complex (see Table 5). The Y199A/F203A has the same activity as that of the 
complement complex. Since the extent of bc1 activity decrease in the double or triple 
alanine substitution mutants containing the F195A mutation is the same as that observed 
for the F195A mutant complex, aromatic residues Y199 and F203 apparently play no 
complementary or auxiliary role to residue F195 in inter-monomer electron transfer.  
 Since the extent of activity change upon the replacement F195 with alanine is 
relatively small, 22% decrease, special attention was paid during data collection. The 
experiments were not only repeated three times but also repeated by different 
investigators. We are very confident that the difference in activity is real and not an 
experimental artifact. As matter of fact the small change in activity observed upon 
replacement of aromatic amino acid with an alanine at residue position 195 is expected, 
because the inter-monomer electron transfer is not in the main path of electron transfer. 
 Absorption spectral analysis of mutant complexes of F195A, F195A/Y199A, 
F195A/F203A, and F195A/Y199A/F203A indicates that the amounts and absorption 
properties of cytochromes b and c1 in these mutant complexes are the same in the 
complement complex. Western blot analysis using antibodies against R. sphaeroides ISP 
and subunit IV also indicate that these mutant complexes have the same amount of ISP and 





Table 5. Characterization of mutants in the cytochrome b of the bc1 complex 
 
Activity Mutants Photosynthetic 




   + + c 
    S.A.b       
    2.21 ± 0.03      
      S.A. b        
     2.50 ± 0.01      
F195A + +     1.76 ±  0.04            1.94 ± 0.02      
Y199A + +     2.21 ±  0.03          2.52 ± 0.03    
F203A + +     2.20 ±  0.03           2.51 ± 0.02    
F195Y + +     2.22 ±  0.03          2.50 ± 0.01    
F195W + +     2.20 ±  0.02         2.49 ± 0.03    
F195H + +     2.21 ±  0.01           2.50 ± 0.02   
F195A/Y199A + +     1.76 ±  0.02            1.95 ± 0.02      
F195A/F203A + +     1.78 ±  0.01           1.93 ± 0.03     
Y199A/F203A + +     2.20 ±  0.02         2.50 ± 0.02     
F195A/Y199A/F203A + +     1.77 ±  0.01            1.96 ± 0.02       
a The purified bc1 complex was in 50 mM Tris-Cl, pH 8.0, containing 200 mM NaCl, 200 
mM histidine, and 0.5% octyl glucoside. 
b Specific activity (S.A.) is expressed as µmol cytochrome c reduced/min/nmol 
cytochrome b at room temperature. 
c  + +, cell growth rate is essentially the same as that of the wild type cells. 
The data presented are mean values ± SD (standard deviation) from three experiments. 
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F195A mutant complex is not due to mutational effects on the assembly of the bc1 protein 
subunits into the chromatophore membrane or to changes in the binding affinity of protein 
subunits in the complex. 
 Although the three pairs of aromatic residues are all located at the dimer interface 
of the cytochrome b subunits, they are not the only residues contributing to the stability of 
the dimer. As observed in the bovine complex, at least 23 residue pairs from a cytochrome 
b subunit make contact at the dimer interface, most are from the transmembrane (TM) 
helices of A and E, from the AB loop and from the N-terminal helix. In addition, the ISP 
TM helix and the head domain make substantial contributions to holding the dimer 
together. As the cytochrome b and ISP subunits are highly conserved, it is reasonable to 
believe that the interaction at the dimer interface would also be conserved. Since the 
structural effect of these mutations is probably creation of small cavities, it is not 
surprising to find that even the triple mutation does not disturb the structural integrity of 
the bc1 dimer.  
 In bovine cytochrome b the three interfacial aromatic pairs display three entirely 
different contact geometries: the Phe179 pair (195 in R. sphaeroides bc1) has an on-edge 
interaction with the two phenyl rings aligned roughly parallel to the membrane plane; with 
an angle between the two planes of 37°; the phenyl rings of the Phe183 pair (199 in 
R. sphaeroides bc1) are stacked on top of each other with an angle of 0°; the Phe187 pair 
(203 in R. sphaeroides bc1) is partially stacked and these two phenyl rings are normal to 
the membrane plane with an angle between the two rings of 34.7°. In biological electron 
transfer complexes such as the cytochrome bc1 complex (1) and photosynthetic reaction 
centers (29), donors and receptors of electron transfer machines are always observed in an 
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on-edge arrangement, as determined by x-ray crystallography. Presumably the on-edge 
interaction between partners provides more efficient electron transfer than other 
orientations. The observed on-edge interaction for the Phe179 pair in the bovine bc1 
structure strongly supports our mutational data indicating that this particular pair mediates 
lateral electron transport between bc1 monomers. In addition, Phe179 has the shortest 
distance to the Qo site, which may also be advantageous for its role as an electron transfer 
mediator between monomers. 
Essentiality of the Aromatic Group in the F195 of Cytochrome b--To establish that 
the loss of ubiquinol-cytochrome c reductase activity in the F195A mutant complex results 
from the loss of an aromatic ring at this position of cytochrome b, mutants with 
conservative substitution at F195 (F195Y, F195W, and F195H), were generated and 
characterized. These three mutants grew photosynthetically at a rate comparable to that of 
the complement cells and, in bc1 complexes in chromatophore membranes or in the 
purified state, have the same ubiquinol-cytochrome c reductase activity as that of the 
complement complex (see Table 5). These results confirm the essentiality of an aromatic 
group at position 195 of cytochrome b in the electron transfer of the bc1 complex. Since 
F195 is located between two bL hemes in the dimeric bc1 complex, and its role is to 
facilitate the lateral, inter-monomer bL-bL electron transfer; the essentiality of aromaticity 
in this residue is apparent. 
Superoxide Anion Generation by Cytochrome bc1 Complexes with the F195A 
Mutation--It has been reported that during electron transfer through the bc1 complex, the 
second electron of ubiquinol can shift from the “low-potential” chain and react with 
molecular oxygen to produce superoxide anion (O2.-). The electron leakage site has been 
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identified as ubisemiquinone of the Qo site or reduced cytochrome bL. If inter-monomer 
bL-bL electron transfer occurs in the bc1 complex and the aromatic group in the F195 
facilitates this lateral electron transfer, one would expect to see an increase in the rate of 
O2.- generation by the F195A mutant, compared to that by the complement complex, due 
to accumulation of electrons in the bL heme of the mutant. This accumulation would 
increase the chance of leakage from the normal pathway, at reduced heme bL or the 
ubisemiquinone of the Qo site, and reaction with oxygen to form O2.-. Therefore, one way 
to confirm that the aromatic group in F195 participates in inter-monomer bL-bL electron 
transfer during bc1 catalysis is to compare superoxide anion radical generation by the 
complement and F195A mutant complexes.   
Although the rate of superoxide anion production by the cytochrome bc1 complex 
can be determined by measuring the decrease in rate of cytochrome c reduction in the 
presence of superoxide dismutase under conditions of continuous turnover of the bc1 
complex, the small rate of superoxide anion formation, compared to the normal rate of 
cytochrome c reduction, compromises the accuracy of this method. MCLA has a high 
sensitivity for O2.- in the neutral pH range (30,31). The MCLA chemiluminescence 
method, which has been widely used to detect O2.- (10, 32-34), is 95 times more sensitive 
than the cytochrome c reduction method (35). However, use of the MCLA- O2.- 
chemiluminescence method to determine the rate of superoxide anion production during 
continuing turnover of the bc1 complex (in the presence of ubiquinol and cytochrome c), 
encounters a high background rate of O2.- production resulting from the non-enzymatic 
oxidation of ubiquinol by cytochrome c, making it difficult to unambiguously compare 
rates of O2.- generation in complement and F195A mutant complexes. This difficulty has 
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been overcome by measuring the chemiluminescence of the MCLA-O2.- adduct during a 
single turnover of bc1 complex, using the Applied Photophysics stopped-flow reaction 
analyzer SX.18 MV. By leaving the excitation light source off, the chemiluminescence of 
MCLA-O2.-, generated when cytochrome bc1 complex is mixed with ubiquinol and 
MCLA, is registered in light emission. Since the system contains no cytochrome c, 
chemiluminescence of MCLA- O2.-, resulting from non-enzymatic oxidation of ubiquinol 
by cytochrome c, is eliminated. This method enables us to accurately evaluate changes in 
the rate of superoxide anion generation by various bc1 complexes.   
Figure 21 shows actual tracings of superoxide generation by wild-type and F195A 
mutant bc1 complexes. MCLA chemiluminescence induced by bc1 complex reaches peak 
intensities after approximately 0.06 sec at room temperature and then decays. No 
detectable luminescence is detected when bc1 complex is omitted from the enzyme- 
containing solution or Q0C10BrH2 is omitted from the substrate-containing solution. 
Addition of superoxide dismutase to either the substrate or enzyme solution completely 
abolishes luminescence, indicating that O2.- is responsible for the luminescence observed.   
Maximum peak height induced by the F195A mutant complex (0.13 volts) is about three 
times higher than that reached by the wild-type complex. 
 Table 6 compares the rates of O2.- generation by the complement and mutant 
cytochrome bc1 complexes. Oxidation of ubiquinol by complement and F195A mutant 
complexes produces 0.17 and 0.49 XO units of O2.- per mg protein, respectively. A similar 
increase in the rate of O2.- production is observed in mutant complexes of F195A/Y199A, 
F195A/F203A, and F195A/Y199A/F203A. However, the rates of O2.- production by 
mutant complexes Y199A, F203A, and Y199A/F203A are similar to that  of the 
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complement complex. These results support the idea that the decrease in bc1 activity in the 
F195 mutant complex results from interruption of the inter-monomer bL-bL electron 
transfer, facilitated by the aromatic group in position F195. 
Effect of Oxygen on Cytochrome c Reduction by Cytochrome bc1 Complex--Table 
7 shows the effect of oxygen on the cytochrome bc1 activity in purified complexes from 
wild type and mutants F195A, Y199A and F203A. The complement, Y199A and F203A 
mutant complexes catalyzed electron transfer, from ubiquinol to cytochrome c, at a rate of 
2.5 µmol cytochrome c reduced per min per nmol cytochrome b at 23 ˚C under aerobic 
conditions. Removal of oxygen from the assay system increases the activities of these four 
complexes by 4% (2.6 µmol cytochrome c reduced per min per nmol cytochrome b). It 
should be noted that this activity increase is not due to the inhibition of the contaminated 
cytochrome c oxidase in the bc1 preparation, since addition of sodium azide to the assay 
mixture, under aerobic conditions, does not increase the rate of cytochrome c reduction. 
Addition of superoxide dismutase to the assay mixture causes a 5.2 % activity decrease in 
the complement, Y199A and F203A cytochrome bc1 complexes. Apparently the O2.- 
generated from the electron leak at the Qo site is capable of reducing cytochrome c at a 
slightly lower rate than normal electron transfer through bc1 complex. Addition of 
superoxide dismutase to the assay system converts the O2.- into hydrogen peroxide, which 
reduces cytochrome c very slowly, and thus decreases the rate of cytochrome c reduction. 
From the activity of cytochrome bc1 complex, determined by reduction of cytochrome c in 
the presence or absence of oxygen, one can estimate the rate of cytochrome c reduction by 







Figure 21. Tracings of superoxide generation in wild-type and mutant F195A 
cytochrome bc1 complexes. To measure the superoxide anion production during the pre-
steady state reaction of the reduction of the bc1 complex by ubiquinol, stopped-flow assays 
were carried out at 230C in an Applied Photophysics stopped-flow reaction analyzer SX 
18MV by mixing 1:1 solutions A and B. Solution A consisted of 100 mM Na+/K+ 
phosphate buffer, pH 7.4, containing 1 mM EDTA, 1 mM KCN, 1 mM NaN3, 0.1% BSA, 
0.01% DM and 9 µM bc1 complexes. Solution B was the same as solution A except that 
the bc1 complex was replaced with 50 µM Q0C10BrH2 and 4 µM MCLA. For each sample, 
eight kinetic traces were averaged. For control, either bc1 complexes or Q0C10BrH2 were 






Table 6. Production of superoxide anion by purified wild-type and mutant complexes 
Strains Superoxide aniona 
 XO units / mg protein 
Wild type 0.17 ± 0.02 
F195A 0.49 ± 0.01 
Y199A 0.16 ± 0.02 
F203A 0.17 ± 0.03 
F195A/Y199A 0.47 ± 0.03 
F195A/F203A 0.49 ± 0.02 
Y199A/F203A 0.18 ± 0.02 
F195A/Y199A/F203A 0.48 ± 0.01 
a XO units are defined under “Experimental Procedures.” For the experimental 






Table 7. Effect of oxygen on the activity of cytochrome bc1 complex purified from wild 
type and mutants  
Specific activitya Preparations 
Aerobic Anaerobic 
 µmol cyt c red /min /nmol cyt b 
Wild type 2.50 ± 0.01 2.60 ± 0.03 
F195A 1.94 ± 0.02 2.39 ± 0.04 
Y199A 2.52 ± 0.02 2.60 ± 0.03 
F203A 2.51 ± 0.03 2.61 ± 0.03 
a To measure the effect of oxygen on bc1 activity, 1 ml of assay mixture containing 100 
mM Na+/K+ phosphate buffer, pH 7.4, 300 µM EDTA, 100 µM cytochrome c, and 25 µM 
Q0C10BrH2 was placed in the main chamber, and a 10-µl aliquot of enzyme with 
cytochrome b of 1µM was in the side arm of a Thunberg cuvette. Complete anaerobic 
conditions were achieved by evacuating and flushing with argon five times. The reaction 
was started by tipping the bc1 complex solution in the side arm into the main chamber. The 
measurement and calculation of activity were as described in “Experimental Procedures”.  
The data presented are mean values ± SD from five experiments. 
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           When bc1 complex from mutant F195A was assayed in the presence and absence of 
oxygen, the activities were 1.93 and 2.39 µmol cytochrome c reduced per min per nmol 
cytochrome b, respectively. This amounts to a 24 % activity increase in the absence of 
oxygen. Under aerobic conditions, addition of superoxide dismutase to the assay mixture 
causes the activity of the F195A mutant complex to decrease from 1.93 to 1.70 µmol 
cytochrome c reduced per min per nmol cytochrome b. This indicates that 12 % of the 
observed activity (reduction of cytochrome c) is due to O2.-. The disruption of electron 
transfer between the two bL hemes in dimeric cytochrome bc1 complex enhances (from 5.2 
to 12%) the electron leakage and decreases (2.61 to 2.39 µmol cytochrome c reduced per 
min per nmol cytochrome b) the normal electron transfer rate during oxidation of 
ubiquinol and reduction of cytochrome c. Since under the anaerobic conditions the activity 
of F195A mutant complex is not restored to the level of the activity of the complement 
complex, activity loss due to disruption of electron transfer between the two hemes bL can 
not attributed entirely to electron leak to oxygen. About half of the activity loss is due to 
disruption of electron transfer between the two hemes bL. In the presence of inter-
monomer electron transfer, the electron at Qo (either at bL or ubisemiquinone) of one 
monomer can be oxidized by the two hemes bH of the complex. When inter-monomer 
electron transfer is interrupted, as in the F195A mutant complex, the electron at heme bL 
can only be oxidized by heme bH of the same monomer; this accounts for a 9% decrease of 
activity. Another explanation for activity decrease in the F195A mutant complex is the 
relatively more oxidized state of hemes bL in dimeric bc1 complex with inter heme bL 
electron transfer than in those without. This more oxidized state of heme bL would 
facilitate electron transfer from ubisemiquinone at Qo site. The fact that disruption of 
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electron transfer between two bL hemes of dimeric complex causes a decrease of activity 
indicates that both monomers are not functioning independently, some sort of negative 
cooperativity does exist (6). 
Effect of F195A on EPR Characteristics of the b Cytochrome--Although evidence 
presented above clearly demonstrates that the loss of bc1 complex activity in mutants, 
F195A, F195A/Y199A, F195A/F203A, and F195A/Y199A/F203A, correlates with the 
leakage of electrons that normally shuttle between the two bL hemes through F195, 
whether or not mutation F195A affects the microenvironments of the cytochromes b is 
unknown. To test this possibility, EPR characteristics of the b cytochromes in cytochrome 
b F195A and wild type were examined after samples were reduced with sodium ascorbate 
to eliminate the overlapping signal from cytochrome c1. As shown in Figure 22, this 
mutant has EPR characteristics identical to those of the wild-type complex, with features 
at g = 3.53 and g = 3.77 previously assigned to cytochrome bH and bL, respectively, and a 
g = 4.29 signal thought to be due to nonspecifically bound iron (III) (36). These data 
indicate that substitution of F195 with alanine has no significant effect on the 
environments of cytochrome b heme. This mutation also has no effect on the midpoint 






Figure 22. The EPR spectra of b cytochromes in purified complexes from wild type 
and cytochrome b F195A. Purified cytochrome bc1 complexes (300 µM cytochrome b) 
were treated with just enough ascorbate solution to fully reduce cytochrome c1 and frozen 
in liquid nitrogen. EPR spectra were recorded at 8.5 K on a Bruker EMX EPR 
spectrometer equipped with an Air Products flow cryostat with the following instrument 
settings: microwave frequency, 9.25 G; microwave power, 107.93 milliwatts; modulation 
amplitude, 20 G; modulation frequency, 100 KHz; time constant, 655 ms; sweep time, 
167.8 s; conversion time, 163.8 ms.  
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THE ROLE OF AN EXTRA FRAGMENT OF CYTOCHROME b (RESIDUES 309-




 Sequence alignment of cytochrome b of the cytochrome bc1 complex from various 
sources reveals that bacterial cytochrome b contains an extra fragment located between the 
amphipathic helix ef and the transmembrane helix F. To study the role of this fragment in 
bacterial cytochrome bc1 complex, Rhodobacter sphaeroides mutants expressing His-
tagged cytochrome bc1 complexes with mutations at various positions of this fragment 
(residues 309-326) were generated and characterized. The cytb-∆(309-326) and cytb-(309-
326)A bc1 complexes, in which all residues of this fragment are deleted or substituted with 
alanine, respectively, have about 20% of the bc1 activity found in the complement 
complex. Mutant complexes of cytb-(309-311)A, cytb-(312-314)A, cytb-(315-317)A, 
cytb-(318-321)A, cytb-(322-323)A, cytb-(324-326)A, cytb-(F323A), and cytb-(S322A) 
have, respectively, 87, 85, 89, 100, 32, 90, 100 and 32% of the bc1 activity detected in the 
complement complex, indicating that the S-322 of cytochrome b is critical. The gx signal 
of the [2Fe-2S] cluster in the cytb-(S322A) mutant complex becomes broadened and shifts 
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to g = 1.76. Replacing the Ser-322 of cytochrome b with Thr, Tyr, or Cys results in mutant 
complexes having the same bc1 activity and EPR characteristics of the [2Fe-2S] cluster as 
the complement complex. The rate of superoxide anion (O2-.) generation, measured during 
the oxidation of ubiquinol, is 4 times higher in the cytb-(S322A) mutant complex than in 
the complement or mutant complexes of S322T, S322Y, or S322C. These support the idea 
that alanine substitution at S-322 of cytochrome b causes conformational changes of Qo 
site by weakening the binding between cytochrome b and ISP through hydrogen bonding 
provided by the hydroxyl group of this residue. This change facilitates electron leakage 
from the Qo site to react with molecular oxygen to form superoxide anion thus decreasing 
the bc1 activity.  
 
Introduction 
Study of cytochrome bc1complex (Complex III) has advanced substantially as a 
result of molecular genetic manipulation of bacterial complex. Although bacterial enzymes 
have simpler subunit composition than their mammalian counter parts, the sizes of core 
subunits (cytochrome b, ISP and cytochrome c1) are generally larger. Sequence alignment 
of bacterial cytochrome b, cytochrome c1, and ISP with their counterparts in the 
mitochondrial complexes reveals four extra fragments in bacterial cytochrome b, one each 
in cytochrome c1 and ISP (1).  
 Are these extra fragments required for bc1 complex? One effective way to answer 
this question is by site-directed mutagenesis of residues in these extra fragments followed 
by stability and functional assay of mutant complexes. By using this approach, the 
cytochrome c1 extra fragment and the N-terminus extra fragment of cytochrome b from R. 
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sphaeroides are found to be nonessential. The ISP extra fragment is required for structural 
stability of ISP in the complex (2), and the C-terminus extra fragment of cytochrome b is 
essential for maintaining structural integrity of the complex (3). However, the knowledge 
of the role of the second and third extra fragments of cytochrome b in R. sphaeroides bc1 
complex is still lacking.  
 The third extra fragment of cytochrome b (residues 309 to 326 in R. sphaeriodes ) 
is in close proximity to the Qo site where electrons from ubiquinol are bifurcated 
according to the “proton-motive Q-cycle” mechanism (4). At the Qo site, the first electron 
of ubiquinol is transferred through the so-called “high-potential” chain consisting of [2Fe-
2S] and heme c1. The second electron of ubiquinol is passed through the “low-potential” 
chain including hemes bL and bH. It has been reported that, during the electron transfer 
through the bc1 complex, the second electron of ubiquinol can shift from the low potential 
chain and react with molecular oxygen to form superoxide anion (O2-.) (5-12). The 
electron leakage site has been thought to be located at the reduced cytochrome bL or 
ubisemiquinone of the Qo site. Thus, studies the role of the third extra fragment in R. 
sphaerodies cytochrome b may help to understand structural elements involved in 
structural stability of the Qo site and thus lead to understand the bc1 complex function.   
 Herein we report generation of R. sphaeroides mutants expressing His-tagged 
cytochrome bc1 complexes with deletion or substitution at various positions in the third 
extra fragment of cytochrome b to investigate the role of this fragment in the bc1 complex. 
The photosynthetic growth behavior, the bc1 activity, and the amount of cytochrome b, 
cytochrome c1, ISP and subuit IV in the chromatophore membrane and the purified state of 
the complement and mutants, were determined and compared to identify the critical amino 
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acid residue(s). The effect of mutations on EPR spectra of ISP and on superoxide anion 
generation during ubiquinol oxidation by the complex is also examined. 
 
Experimental Procedures 
 Materials--Cytochrome c (horse heart, type III), hypoxanthine, and superoxide 
dismutase (SOD), and xanthine oxidase were purchased from Sigma Chemical Co. 
Dodecylmaltoside (DM) and octylglucoside were from Anatrace. Nickel nitrilotriacetic 
acid (Ni-NTA) gel and a Qiaprep spin Miniprep kit were from Qiagen. 2-Methyl-6-(4-
methoxyphenyl)-3,7-dihydroimidazol [1,2-α]pyrazin-3-one, hydrochloride (MCLA) was 
from Molecular Probes, Inc. 2,3-Dimethoxy-5-methyl-6-(10-bromodecyl)-1,4-benzoquinol 
(Q0C10BrH2) was prepared in our laboratory as previously reported (13). All other 
chemicals were of the highest purity commercially available. 
 Growth of Bacteria--E. coli cells were grown at 37 °C in LB medium. Extra-rich 
media, e.g. TYP (1.6 g Bact-tryptone, 1.6 g Bacto-yeast extract, 0.5 g NaCl and 0.25 g 
K2HPO4 in 100 ml medium), were used in procedures for the rescue of single-stranded 
DNA or the purification of low copy number plasmids (14). For photosynthetic growth of 
the plasmid-bearing R. sphaeroides BC17 cells an enriched Siström's medium containing 
5 mM glutamate and 0.2% casamino acids was used. Photosynthetic growth conditions for 
R. sphaeroides were essentially as described previously (15). Cells harboring the mutated 
cytochrome b gene on the pRKD418-fbcFBmCHQ plasmid were grown photosynthetically 
for one or two serial passages to minimize any pressure for reversion. The inoculation 
volumes used for photosynthetic cultures were at least 5% of the total volume. Antibiotics 
were added to the following concentrations: ampicillin (125 µg/ml), kanamycin sulfate 
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(30 µg/ml), tetracycline (10 µg/ml for E. coli and 1 µg/ml for R. sphaeroides), and 
trimethoprim (100 µg/ml for E. coli and 30 µg/ml for R. sphaeroides).  
Generation of R. sphaeroides Strains Expressing the His6-Tagged Cytochrome bc1 
Complexes with Mutations at the Extra Fragment of Cytochrome b (Residues 309-326)--             
Mutations were constructed by site-directed mutagenesis using the Altered Sites II 
mutagenesis system from Promega or the QuikChange site-directed mutagenesis kit from 
Stratagene. The cytb-(309-326)A mutant was constructed by the Altered Sites II 
mutagenesis method using single-stranded pSELNB3503 (16) as template and the 
following mutant oligonucleotide as the annealing primer, 5’-GCGATCCTGCGCGCC 
TTCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCGC
CGCCGACGCCAAGTTCT-3’. The underlined bases correspond to the genetic codes for 
the target mutated amino acids. Other mutants were constructed by the QuikChange site-
directed mutagenesis method, using a supercoiled double-stranded pGEM7Zf(+)-fbcFB as 
template and a forward and a reverse primer for PCR amplification. The pGEM7Zf(+)-
fbcFB plasmid (2) was constructed by ligating the EcoRI-XbaI fragment from 
pSELNB3503 into EcoRI and XbaI sites of the pGEM7Zf(+) plasmid. The primers used 
are given in Table 8.  
Following mutagenesis, a 962-base pair BstEII-XbaI fragment from pSELNB3503 or 
pGEM7Zf(+)-fbcFB plasmid containing the mutant cytochrome b gene was ligated into 
BstEII and XbaI sites of the low copy number plasmid, pRKD418-fbcFBKmBXCHQ, to 
generate the pRKD418-fbcFBmCHQ plasmid. Loss of kanamycin resistance was then used 
to screen for recombinant plasmids. The pRKD418-fbcFBmCHQ plasmid in E. coli S17-1 
cells were conjugated into R. sphaeroides BC17 cells by a plate-mating procedure (15). 
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The presence of engineered mutations and the absence of any additional changes in the 
template region were confirmed by DNA sequencing of the 962-base pair BstEII-XbaI 
fragment before and after photosynthetic growth of the cells as previously reported (15). 
Expression plasmid pRKD418-fbcFBmCHQ was purified from an aliquot of a semi-aerobic 
and photosynthetic culture using the Qiagen Plasmid Mini Prep kit. Since R. sphaeroides 
cells contain four types of endogenous plasmids, the isolated plasmids lacked the purity 
and concentration needed for direct sequencing. Therefore, a 1,883-base pair DNA 
segment containing the mutation sequence was amplified from the isolated plasmids by 
PCR and purified by 1% agarose gel electrophoresis. The 1,883-base pair PCR product 
was recovered from the gel with an extraction kit from Qiagen. DNA sequencing and 
oligonucleotide syntheses were performed by the Recombinant DNA/Protein Core Facility 
at Oklahoma State University. 
 Enzyme Preparations and Activity Assay--Chromatophores were prepared, from 
which the His6-tagged cytochrome bc1 complexes were purified, as previously reported 
(16). Quantification of the bc1 complexes was performed according to published methods 
using extinction coefficients of 28.5 mM-1cm-1 at 563-578 nm for cytochrome b (17), and 
17.5 mM-1cm-1 at 553-539 nm for cytochrome c1 (18). To assay ubiquinol-cytochrome c 
reductase activity, chromatophores or purified cytochrome bc1 complexes were diluted 
with 50 mM Tris-Cl, pH 8.0, containing 200 mM NaCl and 0.01% DM to a final 
concentration of cytochrome b of 3 µM. Appropriate amounts of the diluted samples were 
added to 1 mL of assay mixture containing 100 mM Na+/K+ phosphate buffer, pH 7.4, 300 
µM EDTA, 100 µM cytochrome c, and 25 µM Q0C10BrH2. 30 µM potassium cyanide was 
added to the assay mixture when bc1 activity in chromatophores was determined. For 
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determination of apparent Km for Q0C10BrH2, various concentrations of Q0C10BrH2 were 
used. Activities were determined by measuring the reduction of cytochrome c (the increase 
of absorbance at 550 nm) in a Shimadzu UV-2401 PC spectrophotometer at 23 0C, using a 
millimolar extinction coefficient of 18.5 for calculation. The non-enzymatic oxidation of 
Q0C10BrH2, determined under the same conditions in the absence of enzyme, was 
subtracted from the assay. 
Measurement of Superoxide Anion Generation--Superoxide anion generation by the 
cytochrome bc1 complex was determined by measuring the chemiluminescence of MCLA-
O2-. adduct, in an Applied Photophysics stopped-flow reaction analyzer SX.18MV 
(Leatherhead, England), by leaving the excitation light off and registering light emission, 
as described previously (12). Reactions were carried out at 23 °C by rapid mixing 1:1 
solutions A and B. Solution A contains 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM 
EDTA, 1 mM KCN, 1 mM NaN3, 0.1% BSA, 0.01% DM and an appropriate amount of 
wild-type or mutant bc1 complex. Solution B was the same as A with bc1 complex being 
replaced with 50 µM Q0C10BrH2 and 4 µM MCLA. O2-.generation is expressed in XO 
units. One XO unit is defined as chemiluminescence (maximum peak height of light 
intensity) generated by 1 unit of xanthine oxidase, which equals 2.71 V from an Applied 
Photophysics stopped-flow reaction analyzer SX.18MV, when solution A containing 100 
mM Na+/K+ phosphate buffer, pH 7.4, 100 µM hypoxanthine, 4 µM MCLA, and 1 mM 
NaN3 is mixed with solution B containing 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 
mM NaN3, and 50 units/ml of xanthine oxidase. 
Quantification of Endogenous Ubiquinone in Purified bc1 Complexes--Ubiquinones 
were extracted from the purified bc1 complexes with cyclohexane according to the 
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procedure reported by Redfearn (19). A millimolar extinction coefficient of 12.25 mM–
1cm–1 was used to as the difference in absorption of the oxidized and reduced forms of Q at 
275 nm. 
Differential Scanning Calorimetry--Calorimetric measurements were performed 
with a CSC 6100 NanoII DSC. The reference and sample solutions were carefully 
degassed under vacuum for 15 min prior to use. A 0.50-ml bc1 solution, 2 mg/ml, in 
50 mM K+/Na+ phosphate buffer, pH 7.4, containing 100 mM KCl and 0.002% DM, was 
placed in the sample capillary cell, and the same amount of buffer was placed in the 
reference capillary cell. All DSC scans reported in this study were run at a rate of 10C/min. 
After the first scan, the samples were cooled to the original temperature and rescanned. 
Since after the first scan the protein was completely and irreversibly denatured, no 
thermotransition peaks were observed in the second scan. Thus the second scan could be 
used as a baseline. All thermodynamic analyses were carried out according to the program 
known as CpCal from the Nano DSC program group.  
Other Biochemical and Biophysical Techniques--Protein concentration was 
determined by the method of Lowry et al. (20). SDS-PAGE was performed according to 
Laemmli (21) using a Bio-Rad Mini-Protean dual slab vertical cell. Samples were digested 
with 10 mM Tris-Cl buffer, pH 6.8, containing 1% SDS, and 3% glycerol in the presence 
of 0.4% β-mercaptoethanol for 2 h at 37 °C before being subjected to electrophoresis. 
Western blotting was performed with rabbit polyclonal antibodies against ISP and subunit 
IV of the R. sphaeroides bc1 complex (16). The polypeptides separated by SDS-PAGE gel 
were transferred to polyvinylidene difluoride membrane for immunoblotting. Goat anti-
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rabbit IgG conjugated to alkaline phosphatase or protein A conjugated to horseradish 
peroxidase was used as the second antibody.  
Redox titrations of cytochromes b and c1 in complement and mutant bc1 complexes 
were conducted potentionmetrically according to the previously published method 
(3,22,23), using a Shimadzu model UV-2410 spectrophotometer. 3-ml aliquots of the bc1 
complex (2 µM cytochrome b) in 0.1 M Na+/K+ phosphate buffer, pH 7.0, were used in the 
presence of 20 µM phenazine methosulfate (midpoint redox potential (Em) +80 mV), 20 
µM phenazine ethosulfate (Em +55 mV), 20 µM phenazine (Em -120 mV), 20 µM 
pyocyanine (Em -34 mV), 25 µM 1,4-benzoquinone (Em +293 mV), 25 µM 1,2-
naphthoquinone (Em +143 mV), 25 µM 1,4-naphthoquinone (Em +36 mV), 50 µM 
duroquineone (Em +5 mV), 70 µM 2,3,5,6-tetramethyl-p-phenylenediamine (Em +260 mV), 
and 15 µM 2-hydroxy-1,4-naphthoquinone (Em -145 mV) as mediators. Samples were 
poised at desired redox potentials (Eh) using sodium dithionite or potassium ferricyanide 
solution.   
Low temperature EPR spectra were recorded with a Bruker EMX EPR 
spectrometer equipped with an Air Products flow cryostat. The instrument setting details 





Table 8. Oligonucleotides used for site-directed mutagenesis (F and R in the parentheses 










































































a The underlined bases correspond to the genetic codes for the amino acid(s) to be mutated. 
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 Results and Discussion 
The Requirement of an Extra Fragment of Cytochrome b (residues 309-326) for the 
Cytochrome bc1 Complex--R. sphaeroides cytochrome b has an extra fragment that 
corresponds to residues 309-326 with a sequence of –TADVWVVQIANFISFGII– (see 
Figure 10). This fragment is located between the amphipathic helix ef, a key structural 
component of the Qo site, and the transmembrane helix F of the cytochrome b sequence, in 
the modeled 3-D structure of R. sphaeroides bc1 complex (see Figure 23) or in the low 
resolution 3-D structure of the R. capulatus bc1 complex (24). To probe the role of this 
fragment, R. sphaeroides mutants expressing His6-tagged bc1 complexes with deletion or 
substitution at various positions of the extra fragment were generated and characterized. 
When this extra fragment is deleted from the cytochrome b sequence, the resulting 
cells [cytb-∆(309-326)] after a long lag time (when the wild-type cells have grown to 
stationary phase under the same conditions) starts to grow photosynthetically at a rate 
comparable to that of the complement (wild-type) cells. Chromatophores prepared from 
this mutant have only 20% of the bc1 activity found in the complement chromatophores 
(see Table 9). A similar electron transfer activity is found in the bc1 complex purified from 
this mutant chromatophores (see Table 9). These results indicate that this region is 
required for bc1 complex activity.  
To further confirm that a decrease in bc1 activity found in the [cytb-∆(309-326)] 
mutant complex results from the essentiality of this extra fragment for the bc1 complex, 
and not from improper protein assembly or folding due to the large deletion, a mutant with 







Figure 23. Location of an extra fragment of cytochrome b (residues 309-326) in the 
proposed structural model of R. sphaeroides bc1 complex. One monomer (left) is 
displayed in solid ribbons, and the symmetric monomer (right) is displayed in three-tread-
line ribbons. Cytochrome c1 is silver; ISP is brown; subunit IV is rust; cytochrome b is 




Table 9. Characterization of mutants in the cytochrome b of the bc1 complex 
 
The bc1 complex activity  Mutants Photosynthetic 




   + + c 
S.A.b 
    2.21 (100%)     
 S.A. b 
     2.50 (100%)      
cytb-∆(309-326) + d     0.44 (20%)            0.53 (21%)       
cytb-(309-326)A +      0.46 (21%)         0.52 (21%)    
cytb-(309-311)A + +     1.90 (86%)           2.18 (87%)    
cytb-(312-314)A + +     1.96 (89%)          2.13 (85%)    
cytb-(315-317)A + +     2.06 (93%)       2.23 (89%)    
cytb-(318-321)A + +     2.21 (100%)           2.49 (100%)   
cytb-(322-323)A +      0.69 (31%)            0.80 (32%)       
cytb-(324-326)A + +     2.01 (91%)          2.25 (90%)     
cytb-(S322A) +      0.68 (31%)         0.81 (32%)     
cytb-(F323A) + +     2.22 (100%)            2.52 (100%)        
cytb-(S322T) + +     2.21 (100%)            2.51 (100%)        
cytb-(S322C) + +     2.10 (95%)            2.45 (98%)        
cytb-(S322Y) + +     2.08 (94%)            2.43 (97%)        
a The purified bc1 complex was in 50 mM Tris-Cl, pH 8.0, containing 200 mM NaCl, 200 
mM histidine, and 0.5% octyl glucoside. 
b Specific activity (S.A.) is expressed as µmol cytochrome c reduced/min/nmol 
cytochrome b at room temperature. 
c  + + , cell growth rate is essentially the same as that of the wild type cells. 
d +, cells grow photosynthetically with a rate comparable to that of the wild type cells after 
a period of lag. 
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characterized. This mutant cell has photosynthetic growth behavior and bc1 activity similar 
to those of the [cytb-∆(309-326)] mutant. These results support the requirement of this 
extra fragment of cytochrome b for the bacterial cytochrome bc1 complex, and suggest that 
the amino acid residues, rather than the length of this fragment, are critical, since the 
alanine-substituted fragment should have the same length and structure as the wild-type 
fragment. 
 Serine-322 Is a Critical Residue in this Extra Fragment of Cytochrome b-- To 
identify critical amino acid residues in this extra fragment, we first located the critical 
regions. Residues in six portions of this fragment were replaced with alanine to generate 
six mutants, cytb-(309-311)A, cytb-(312-314)A, cytb-(315-317)A, cytb-(318-321)A, cytb-
(322-323)A, and cytb-(324-326)A. When these mutants were subjected to photosynthetic 
growth conditions, mutants cytb-(309-311)A, cytb-(312-314)A, cytb-(315-317)A, cytb-
(318-321)A, and cytb-(324-326)A grow photosynthetically at a rate comparable with that 
of the complement cells. However, the cytb-(322-323)A mutant requires a longer lag time 
(>12 hrs) before it starts to grow at a rate comparable to that of the wild-type cells. This 
growth behavoir is similar to that of mutants [cytb-∆(309-326)] and [cytb-(309-326)A]. 
Chromatophores prepared from mutants cytb-(309-311)A, cytb-(312-314)A, cytb-(315-
317)A, cytb-(318-321)A, and cytb-(324-326)A have, respectively, 86, 89, 93, 100, and 
91% of  bc1 activity detected in the complement chromatophores.  Similar activities are 
observed in bc1 complexes purified from these mutant chromatphores (see Table 9). On 
the other hand, chromatophores and purified complex obtained from the cytb-(322-323)A 
mutant has only 31% of bc1 activity found in the complement chromatophores or bc1 
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complex. These results indicate that either one or both residues 322-323 of cytochrome b 
are important.  
 Since residues 322 and 323 of cytochrome b are Ser and Phe, to see which of these 
two residues is essential, mutants cytb-(S322A) and cytb-(F323A) were generated and 
characterized. As shown in Table 9, chromatophores prepared from these two mutants 
have, respectively, 31 and 100% of the bc1 activity found in the complement 
chromatophores, indicating that S-322 of cytochrome b is critical. The S-322 is highly 
conserved in bacterial cytochrome bs. 
  Essentiality of the hydroxyl group in the Ser-322 of Cytochrome b--Absorption 
spectral analysis reveals that the amounts and absorption properties of cytochromes b and 
c1 in mutant complexes of cytb-∆(309-326), cytb-(309-326)A, and cytb-(S322A) are the 
same as those in the complement  complex. Western blot analysis using antibodies against 
R. sphaeroides ISP and subunit IV also indicate that these mutant complexes have the 
same amount of ISP and subunit IV as does the complement complex. Redox potentials of 
cytochromes b and c1 in these mutant complexes are also the same as those in the 
complement complex. Thus, the decrease in bc1 activity in the cytb-(S322A) mutant 
complex is not due to mutational effects on the assembly of the bc1 protein subunits into 
the chromatophore membrane, to changes in the binding affinity of protein subunits in the 
complex, or to change the redox potential of cytochromes b and c1 in the complex.   
  Since S-322 contains a hydroxyl group, it is possible that the loss of bc1 activity in 
the cytb-(S322A) mutant complex results from the mutation abolishing hydrogen bond 
forming ability of the residue at this position of cytochrome b. To confirm this possibility, 
mutants with S-322 substituted with the hydroxyl-containing residues [cytb-(S322T) and 
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cytb-(S322Y)] and the SH-containing residue [cytb-(S322C)] were generated and 
characterized. These three mutants grew photosynthetically at a rate comparable to that of 
the complement cells and, in bc1 complexes in chromatophore membranes or in the 
purified state, have the same electron transfer activity as that of the complement complex 
(see Table 9). These results indicate that a hydrogen bond forming group at position 322 of 
cytochrome b is essential for the electron transfer activity of the bc1 complex. 
   Effect of the Mutation at S322 of Cytochrome b on the Rieske Iron-Sulfur Cluster-
-Figure 24 compares EPR spectra of the Rieske iron-sulfur cluster in complement and 
mutant complexes. When the complement and cytb-(S322A) mutant complexes were 
reduced by a small excess of ascorbate, the EPR signal of the [2Fe-2S] cluster in the 
complement complex is essentially the same as previously reported for the wild-type 
complex, with resonance at gx = 1.800, gy = 1.898, and gz = 2.026. While the signatures of 
gy and gz of [2Fe-2S] in the cytb-(S322A) mutant complex are the same as those detected 
in the complement complex, the gx signature becomes broadened and shifts to g = 1.768,  
indicating that alanine substitution at S322 of cytochrome b perturbs the 
microenvironment of [2Fe-2S] cluster of ISP. As expected, the broadened, gx = 1.768 
signal is observed in mutant complexes of cytb-∆(309-326), cytb-(309-326)A, and cytb-
(322-323)A (see Fig. 24), since these mutant complexes lack the essential hydrogen 
bonding forming hydroxyl group at residue 322 of cytochrome b. 
   Replacing S322 with T, Y, or C, the resulting mutant complexes have EPR 
characteristics of [2Fe-2S] cluster identical to those observed in the complement complex, 
indicating that the presence of a hydrogen bond forming residue at position 322 of 
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cytochrome b is essential for maintaining proper microenvironments of the [2Fe-2S] 
cluster of ISP in the bacterial complex. 
 It has been reported that the gx of bc1 from R. sphaeroides is at g = 1.800 when 
ubiquinone is present but shifts to 1.750 and broadens when ubiquinol is present (3,25). 
When ubiquinone is extracted from chromatophore membranes, the gx signal of 
the"depleted state" is at g = 1.765 and is considerably broader than those seen in the 
presence of either ubiquinone or ubiquinol (26). Although the broadened, gx = 1.768 
resonance observed in the cytb-(S322A) mutant complex resembles the “reduced state” or 
the “depleted state” spectrum, it is not because of changes the redox state of Q or a 
decrease of Q content in the mutant complex, because the EPR spectrum of [2Fe-2S] 
cluster in this mutant complex is detected under the same redox conditions as that of the 
complement complex and the Q content in the cytb-(S322A) mutant complex is the same 
as that in the complement complex.  
 The broadened, gx = 1.768 signal observed in the cytb-(S322A) mutant complex is 
also reminiscent of that observed for the substitution of Leu for Phe-144 (F144L) in the 
cytochrome b from R. capsulatus (23) and of Ser for Thr-160 (T160S) in the cytochrome b 
from R. sphaeroides (15). The F144L bc1 complex in R. capsulatus and the T160S mutant 
complex in R. sphaeroides chromatophores were reported to have a very low turnover rate 
with a broadened, redox state-insensitive, gx value at 1.765. It was suggested that these 
properties of the F144L and T160S complexes resulted from a reduced affinity for quinone 
and quinol at the Qo center of the mutated complexes. Since the Kms for Q0C10BrH2 
determined with mutant complexes of cytb-∆(309-326) and cytb-(S322A) are comparable 
with that of the complement complex, mutational effects observed in the  
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Figure 24. EPR spectra of the [2Fe-2S] cluster of the Rieske iron-sulfur protein in 
purified bc1 complexes from the complement and mutants cytb-∆(309-326), cytb-(309-
326)A, cytb-(322–323)A, cytb-(S322A), and cytb-(S322T). Purified complement and 
mutant bc1 complexes were treated with a small excess of sodium ascorbate solution to 
fully reduce cytochrome c1 and frozen in liquid nitrogen. EPR spectra were recorded EPR 
spectra were recorded at 11 K on a Bruker EMX EPR spectrometer equipped with an Air 
Products flow cryostat with the following instrument settings: microwave frequency, 9.3 
GHz; microwave power, 2.2 milliwatts; modulation amplitudes, 6.3 G;  
modulation frequency, 100 kHz; time constant, 665.4 ms; sweep time: 167.8 s; conversion 
time, 163.8 ms. 
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cytb-(S322A) mutant complex cannot be attributed to the decrease in quinol binding at the 
Qo site. 
 Since S322 is at the tip of this extra fragment of cytochrome b which is located 
between the amphipathic helix ef, a key structural component of the Qo site, and the 
transmembrane helix F, one possibility, which could account for the decreased turnover 
rate of the cytb-(S322A) mutant complex and its reduced state or the high field shift of the 
gx EPR singal is that alanine substitution at S322 causes conformational changes at the Qo 
site, due to weakening putative interaction between ISP and cytochrome b through the loss 
of hydrogen bonding provided by the hydroxyl group of S322, to enhance the electron 
leakage thus decreasing the bc1 activity.   
  Superoxide Anion Generation by Cytochrome bc1 Complexes with the S322A 
Mutation--If the decrease in bc1 activity observed in the cytb-(S322A) mutant complex 
indeed results from the alteration of Qo site to enhance electron leakage, one would expect 
to see an increase in the rate of O2.-generation by the cytb-(S322A) mutant complex, 
compared with that by the complement complex.   
  Figure 25 shows tracings of superoxide generation by complement and cytb-
(S322A) mutant bc1 complexes. The rate of superoxide generation by bc1 complex was 
measured by the chemiluminescence of the MCLA-O2.- adduct during a single turnover of 
bc1 complex (in the absence of cytochrome c) using the Applied Photophysics stopped-
flow reaction analyzer SX.18 MV. Since the system contains no cytochrome c, 
chemiluminescence of MCLA-O2.- resulting from non-enzymatic oxidation of ubiquinol by 
cytochrome c, is eliminated. MCLA chemiluminescence induced by bc1 complex reaches 
peak intensities after approximately 0.06 sec at room temperature and then decays. No 
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detectable luminescence is detected when bc1 complex is omitted from the enzyme-
containing solution or Q0C10BrH2 is omitted from the substrate-containing solution. 
Addition of superoxide dismutase to either the substrate or enzyme solution completely 
abolishes luminescence, indicating that O2.- is responsible for the luminescence observed. 
Maximum peak height induced by the cytb-(S322A) mutant complex is about four times 
higher than that reached by the wild-type complex. 
 Table 10 compares the rates of O2.- generation by the wild-type and mutant 
cytochrome bc1 complexes. Oxidation of ubiquinol by complement and cytb-(S322A) 
mutant complexes  produces 0.19 and 0.72 XO units of O2.- per mg of protein, 
respectively. A similar increase in the rate of O2.- production is observed in mutant 
complexes of cytb-∆(309-326), cytb-(309-326)A, and cytb-(322-323)A. However, the rate 
of Q2.- production by mutant complexes of cytb-(F323A) and cytb-(S322T) are similar to 
that of the wild-type complex. These results support the idea that alanine substitution at 
S322 causes conformational changes at the Qo site, mainly through weakening the 
interaction between ISP and cytochrome b by replacing hydroxyl group at the position of 
322, to facilitate electron leakage to react with molecular oxygen thus decreasing the bc1 
activity. Substituting S322 with threonine does not alter the putative hydrogen bounding 






Figure 25. Tracings of superoxide generation in the cytochrome bc1 complexes of 
wild-type and mutants in cytochrome b. To measure the superoxide anion production 
during the pre-steady state reaction of the reduction of the bc1 complex by ubiquinol, 
stopped-flow assays were carried out at 230C in an Applied Photophysics stopped-flow 
reaction analyzer SX 18MV by mixing 1:1 solutions A and B. Solution A consisted of 100 
mM Na+/K+ phosphate buffer, pH 7.4, containing 1 mM EDTA, 1 mM KCN, 1 mM NaN3, 
0.1% BSA, 0.01% DM and 9 µM bc1 complexes. Solution B was the same as solution A 
except that the bc1 complex was replaced with 50 µM Q0C10BrH2 and 4 µM MCLA. For 
each sample, eight kinetic traces were averaged. For control, either bc1 complexes or 
Q0C10BrH2 were omitted from the above system, or 300 units/ml SOD was added to the 





Table 10.  Production of superoxide anion by purified wild-type and mutant complexes 
Strains Superoxide aniona 
 XO units / mg protein 
Wild type 0.19 ± 0.02 
cytb-∆(309-326) 0.73 ± 0.01 
cytb-(309-326)A 0.72 ± 0.03 
cytb-(322-323)A 0.72 ± 0.02 
cytb-(S322A) 0.72 ± 0.02 
cytb-(F323A) 0.19 ± 0.03 
cytb-(S322T) 0.18 ± 0.03 
a XO units are defined under “Experimental Procedures.” For the experimental conditions, 
see the legend to Fig. 25. The data presented are mean values ± SD from five experiments. 
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Effect of Mutation on the Thermotropic Properties of Cytochrome bc1 Complex--
Since it has been shown that alanine substitution at S322 of cytochrome b decreases the 
bc1 complex activity, perturbs the microenvionment of ISP, and increases the rate of 
superoxide anion radical generation, it is of interest to see whether or not this mutation 
also affects structural stability of the bc1 complex.  Differential scanning calorimetry 
(DSC), a widely used method for determining protein structural stability, was employed to 
compare the stability of complement and mutant complexes.  The lower Tm and ∆H of the 
mutant complex indicate that it is less stable than the complement complex.  
 When the thermotrophic properties of complement and mutant cytb-(S322A) 
complexes were measured by DSC, the mutant complex exhibited a thermodenaturation 
temperature (Tm) of 44.1 ˚C with an enthalpy change (∆H) of 74.0 kcal/mol whereas the 
complement complex showed a Tm of 46.3 ˚C with a ∆H of 96.7 kcal/mol.   Under identical 
conditions, mutant complexes of cytb-∆(309-326), cytb-(309-326)A, and cytb-(S322T) 
showed, respectively, Tms of 43.3, 43.3, and 46.2°C with ∆Hs of 64.1, 63.6, and 95.6 
kcal/mol.  These results indicate that replacing the hydroxyl group bearing amino acid 
residue at the position 322 of cytochrome b with a non-hydroxyl amino acid causes not 
only a decrease in the electron transfer activity but also in the structural stability of the bc1 
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SATURATION TRANSFER ELECTRON PARAMAGNETIC RESONANCE 
AND DIFFERENTIAL SCANNING CALORIMETRY STUDIES OF THE 
INTERACTION BETWEEN CYTOCHROME caa3 AND F1F0-ATP 
SYNTHASE FROM ALKALIPHILIC BACILLUS PSEUDOFIRMUS OF4 
 
Abstract 
The interaction between cytochrome caa3 and F1F0-ATP synthase from the 
alkaliphilic Bacillus pseudofirmus OF4 was studied by differential scanning calorimetry 
(DSC) and by saturation transfer electron paramagnetic resonance (ST-EPR). When these 
two purified complexes are embedded in phospholipids vesicles individually [(cca3) × PL, 
(F1F0) × PL)] or in combination [(cca3+F1F0) × PL] and subjected to DSC analysis, they 
undergo exothermic thermodenaturation with transition temperatures at 69, 57, and 46/75 
˚C, respectively. The ∆H (-9.45 kcal/mol) of protein-phospholipid vesicles containing both 
cytochrome caa3 and F1F0 is smaller than that (-12.3 kcal/mol) of a mixture of protein-
phospholipid vesicles formed from each individual electron transfer complex [(cca3 × PL) 
+ (F1F0 × PL)]. These results suggest that a specific interaction between cytochrome caa3 
and F1F0 exists in the membrane. Further evidence for the interaction between these two 
complexes is provided by ST-EPR studies in which the rotational correlation time of spin-
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labeled caa3 (65 µs) increases significantly when the complex is mixed with F1F0 prior to 
being embedded in phospholipids vesicles (270 µs). From these results, it is concluded that 
at least a part of caa3 and a part of F1F0 form a supermacromolecular complex in this 
bacterial membrane.  
 
Introduction 
  The facultative alkaliphile, Bacillus pseudofirmus OF4, grows well over a pH range 
extending from 7.5 to above 10.5 (1). The organism possesses a branched respiratory chain 
with at least two terminal oxidases, cytochrome bd and cytochrome caa3 (2). Increased 
amounts of cytochrome caa3 are associated with two distinct growth conditions where the 
bulk electrochemical proton gradient (∆p) is low: pH 10.5 (3) or pH 7.5 in the presence of 
protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP) (4). Additionally, a 
CCCP-resistant mutant strain was found to contain constitutively elevated levels of 
cytochrome caa3 when grown at pH 7.5 (4). 
Like mitochondria of eukaryotic organisms and most bacteria, alkaliphilic Bacillus 
pseudofirmus OF4 synthesizes ATP using a proton-coupled F1F0-ATP synthase via 
oxidative phosphorylation (5). The widely confirmed chemiosmotic mechanism for ATP 
synthesis and other membrane-associated bioenergetic work requires establishment of ∆p 
during respiration and photosynthesis. Coupling is achieved by the proton-translocating 
nature of the reversible F1F0-ATP synthase (6). Two properties of proton-coupled 
oxidative phosphorylation by alkaliphilic Bacillus species suggest that above pH 9.5, ATP 
synthesis utilizes a mechanism that depends upon the bulk transmembrane electrical 
potential, the ∆Ψ, but also depends upon a sequestered transfer of protons from the 
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respiratory chain to the ATP synthase. Firstly, the protonmotive driving force is very low 
at pH 10.5 and above, because the needs of pH homeostasis produce a large ∆pH, acid in. 
Nonetheless, the ATP synthesized, as reflected in the observed phosphorylation potential, 
is even greater than at pH 7.5, where the ∆p is three times higher. Secondly, artificially 
imposed diffusion potentials fail to energize ATP synthesis at pH values above 9.5 (7).  
We have hypothesized that robust alkaliphile oxidative phosphorylation at very 
alkaline pH values involves the required respiratory chain proton pumping to the bulk 
phase to establish a ∆p and also involves use of one or more specific respiratory chain 
complexes to transfer protons to F0 sector of the F1F0 ATP-synthase during dynamic 
protein-protein interactions (7). In this way, the proton-translocating F1F0-ATPase 
accesses protons that have not completely equilibrated with the alkaline medium, 
accounting for greater synthesis than anticipated from the measured bulk ∆p and for the 
inefficacy of an imposed bulk potential. The caa3 terminal oxidase is the best candidate for 
that interacting partner both because of its alkali-dependent expression and because of the 
observation that small mutational decreases in the level of this oxidase lead to a non-
alkaliphilic phenotype on non-fermentative substrates (3,8). An alternative hypothesis that 
would not involve protein-protein interactions between a respiratory chain complex and 
the ATP synthase is that alkaliphile oxidative phosphorylation at high pH utilizes protons 
that are sequestered near the membrane surface in some trapped, delocalized manner (9), 
but such hypotheses have not been experimentlly supported and do not account from the 
requirement of specific features of the alkaliphile F1F0-ATPase for ATP synthesis at high 
pH (10).  
129 
 Using methods of differential scanning calorimetry (DSC) and saturation transfer 
electron paramagnetic resonance (ST-EPR), we had earlier been able to detect protein-
protein interactions between the bovine heart mitochondrial cytochrome c oxidase and 
F1F0-ATP synthase in the native membrane state (11). Recently, we used these methods to 
study the interaction between cytochrome caa3 and ATP synthase from alkaliphilic 
Bacillus pseudofirmus OF4 in an attempt to test the hypothesis that protein-protein 
interactions are involved in ATP synthesis. If the assays supported such interactions, they 
could then be used to assess the role of specific features of the ATP synthase and oxidase. 
The DSC study is based on the assumption that if two lipoprotein complexes exist 
separately in a phospholipid vesicle, no difference in thermotropic properties will be 
observed between protein-phospholipid vesicles formed from a mixture of two complexes 
and a mixture of protein-phospholipid vesicles formed individually from each complex. 
Differences in the thermodenaturation temperatures and enthalpy changes would suggest 
formation of a physical complex between cytochrome caa3 and ATP synthase. In the ST-
EPR study, the formation of a physical complex between cytochrome caa3 and ATP 
synthase will be indicated by an increase of rotational correlation time of spin-labeled 
cytochrome caa3. Herein, we report experimental details and results of DSC and ST-EPR 
studies with cytochrome caa3 and ATP synthase embedded in phospholipid vesicles. The 
results of DSC and ST-EPR indicate that cytochrome caa3 does indeed interact directly 






 Materials--4-Maleimide-2,2,6,6-tetramethyl-1-piperidinyl-N-oxyl (MSL), 
Cytochrome c (horse heart, type III) and sodium cholate were from Sigma. Dodecyl 
maltoside (DM) and octyl glucoside were from Anatrace. Asolection was obtained from 
Associated Concentrates, Inc., and purified according to the procedure reported by 
Kagama et al. (12). Centriprep-30 and Centricon-30 were bought from Amicon. Other 
chemicals were of the highest purity commercially available.  
Enzyme Preparations and Assays--Highly purified cytochrome caa3 and F1F0-ATP 
synthase from alkaliphilic Bacillus pseudofirmus OF4 were prepared and assayed 
essentially as reported previously (3,5).   
Preparation of Maleimide Spin-Labeled (MSL) Cytochrome caa3--Alkaliphile, 
Bacillus pseudofirmus OF4 cytochrome caa3, 20 mg/ml in 20 mM Tris-Cl, pH 8.0, 
containing 0.35 M NaCl, 1 mM EDTA, 0.1 mM PMSF, 0.05 % dodecyl maltoside, and 10 
% glycerol was incubated with a 5 molar excess of 4-maleimide-2,2,6,6-tetramethyl-1-
piperidinyl-N-oxyl (MSL) for 1 hour at room temperature. The stock solution of MSL (10 
mM) was made in 10 mM Tris-Cl /sucrose buffer, pH 8.0, containing 20% methanol. After 
incubation, the unreacted MSL was removed by passage through a D-SaltTM Excellulose 
Desalting Column from Pierce, equilibrated with 10 mM Tris-Cl buffer, containg 0.05 % 
dodecyl maltoside. Fractions containing MSL-cytochrome caa3 were pooled and 
concentrated by Centriprep-30 and Centricon-30 to a protein concentration of 
approximately 20 mg/ml. MSL-cytochrome caa3 obtained by this method contains no free 
spin-label. The absence of free spin-label in the preparation was confirmed by the 
conventional EPR spectra. 
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Preparation of Cytochrome caa3 and F1F0 Complex-Phospholipid Vesicles--The 
protein-phospholipid vesicles were prepared by the cholate-dialysis method reported by 
Racker (13). Cytochrome caa3 complex, with or without MSL labeling, alone or in 
combination with F1F0, at a protein concentration of approximately 30 mg/ml, was mixed 
with an asolectin micellar solution (20 mg/ml in 50 mM phosphate buffer, pH 7.4) and a 
sodium cholate solution [20% (w/v) in water]. The final solution contained 7 mg/ml 
protein, 10 mg/ml sodium cholate, and 10.5 mg/ml asolectin. After incubation at 4oC for 
30 min, the solution was dialyzed overnight against 500 volumes of 50 mM phosphate 
buffer, pH 7.4, with four changes of buffer to form vesicles. The protein-phospholipid 
vesicles formed were collected as precipitated by centrifugation at 80000g for 1 h and 
were respended in 50 mM phosphate buffer, pH 7.4, to a protein concentration of suitable 
number. The suspensions were used for the DSC and STEPR experiments. 
Differential Scanning Calorimetry--All calorimetric measurements were performed 
with a CSC 6100 NanoII DSC from Calorimetry Science Corp. The reference and sample 
solutions were carefully degassed under vacuum for 15 min prior to use. A 0.50-ml sample 
in 50 mM K+/Na+ phosphate buffer, pH 7.4, was placed in the sample capillary cell, and 
the same amount of buffer was placed in the reference capillary cell. All DSC scans 
reported in this study were run at a rate of 10C/min. After the first scan, the samples were 
cooled to the original temperature and rescanned. Since after the first scan the protein was 
completely and irreversibly denatured, no thermotransition peaks were observed in the 
second scan. Thus the second scan could be used as a baseline. All thermodynamic 
analyses were carried out according to the program known as CpCal from the Nano DSC 
program group.  
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EPR Measurements--All EPR measurements were made with a Bruker EMX EPR 
spectrometer, using an aqueous quartz flat cell. The temperature of the microwave cavity 
was controlled by circulation of cooled nitrogen gas from a modified variable temperature 
housing assembly equipped with an electric temperature sensor. Conventional EPR spectra 
were recorded with instrument settings as follows: field modulation frequency, 100 kHz; 
modulation amplitute, 8 G; microwave frequency, 9.757 GHz; microwave power, 10.78 
mW; time constant, 1310.72 ms. Saturation transfer EPR spectra were recorded using the 
same instrument settings as those described by Thomas et al. (14) and Poore et al. (15). A 
field modulation of 8 G and microwave frequency of 9.757 GHz were employed with 
phase-sensitive detection at 100 Hz (second harmonic) 900 out of phase. Incident 
microwave power was 107.80 mW. The phase was adjusted to minimize the second 
harmonic signal. Approximate rotational correlation time (τ2) was obtained from the ratio 
of the two field lines (L”/L). The calibration curve of Thomas et al. (14) derived from 
isotropic tumbling of MSL-labeled hemoglobin was used in the calculation. 
Other Analytical Methods--Protein concentration was determined by the biuret 
method (16), using bovine serum albumin as the standard (assuming 1 mg/ml has an A279 








Results and Discussion 
Thermotropic Properties of Cytochrome caa3 and F1F0-synthase Embedded in 
Phospholipid Vesicles--To unambiguously study the interaction between cytochrome caa3 
and F1F0-synthase from alkaliphilic Bacillus pseudofirmus OF4, DSC studies were carried 
out with both complexes embedded in phospholipid (asolectin) vesicles, because these 
enzymes in protein-phospholipid vesicles should have an environment similar to that in 
membrane. The isolated complexes, singly or in combination, were embedded in 
phospholipids vesicles by the cholate dialysis method (13). A constant phospholipid to 
protein ratio of 1.5 was used. The ratio between cytochrome caa3 and F1F0-synthase varies 
from 0.25 to 1.5. If the two lipoprotein complexes have no specific interaction, then no 
difference in DSC characteristics should be observed between phospholipids vesicles 
embedded with a mixture of two complexes and a mixture of phospholipids vesicles 
embedded with one or the other complex. In other words, differences in the 
thermodenaturation temperatures (Tm) and enthalpy changes (∆H) would suggest 
formation of a physical complex between these two lipoproteins. 
Figure 26 shows the differential scanning calorimetric thermograms of alkaliphilic 
Bacillus pseudofirmus OF4 F1F0-synthase and cytochrome caa3 embedded in 
phospholipids singly or in combination. When F1F0-synthase was incorporated into 
phospholipid vesicles and subjected to DSC analysis, an exothermic peak at 57.2 0C with 
the enthalpy change of -4.22 kcal/mol of protein was observed (see Fig. 26A). Purified 
cytochrome caa3 also shows a single transition with ∆H = -8.19 kcal/mol of protein and 
Tm = 68.5 0C when embedded into phospholipids vesicles as shown in Fig.26B. As 
expected, when the mixture of protein-phospholipid vesicles formed individually from 
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F1F0-synthase and cytochrome caa3 was subjected to DSC analysis under the identical 
condition, two exothermic transient peaks at 56.8 and 68.9 0C with the ∆H of -12.3 
kcal/mol of protein were obtained (see Fig. 26D). These data are summaries of the 
thermotropic properties of F1F0-synthase-phospholipid vesicles and cytochrome caa3-
phospholipid vesicles. However, the protein-phospholipid vesicles formed from a mixture 
of F1F0-synthase and cytochrome caa3 have Tm1 = 45.5 0C and Tm2 = 74.6 0C with ∆H = -
9.45 kcal/mol of protein (see Fig. 26C). These data are significantly different from those 
observed with a mixture of phospholipids vesicles embedded individually with F1F0-
synthase or cytochrome caa3, suggesting that there is some interaction between these two 
complexes.  
Figure 27 compares the thermodenaturation enthalpy changes of phospholipid 
vesicles formed with mixtures of cytochrome caa3 and F1F0-synthase at various molar 
ratios and of mixtures of phospholipid vesicles of individual complexes. The value of the 
difference in ∆H increases as F1F0-synthase is increased. The maximum difference is 
obtained when approximately one mol of F1F0-synthase per mol cytochrome caa3 is used. 
This suggests that the interaction between cytochrome caa3 and F1F0-synthase is specific. 
The accuracy of assessment of the stoichiometry between the two complexes may have 
been compromised by uncertainty concerning the intactness of each complex.  
As discussed earlier (11,17-19), the energy for the exothermic transition of an 
electron transfer complex embedded in phospholipids vesicles is derived from the 
collapse, upon thermodenaturation, of a strained interaction between unsaturated fatty acyl 
groups of phospholipids and a protein surface on the electron transfer or other lipoprotein 





Figure 26. DSC curves of alkaliphile B. pseudofirmus OF4 F1F0 and cytochrome caa3 
embedded in phospholipids singly or in combination. The molar ratio of F1F0 and caa3 
is 1 and the weight ratio of phospholipids to protein is 1.5 in all cases. These vesicles are 
prepared by the cholate dialysis method. Spectrum A shows the exothermic 
thermodenaturation of 0.5 mg F1F0 embedded in phospholipid vesicles. Spectrum B is the 
DSC thermogram of 0.105 mg caa3 embedded in phospholipid vesicles. Spectrum C is the 
DSC profile of phospholipid vesicle embedded with a mixture of 0.5 mg F1F0 and 0.105 
mg caa3. Spectrum D is a mixture of phospholipid vesicles, which include 0.5 mg F1F0 






Figure 27. Comparison of thermodenaturation enthalpy changes of phospholipids 
vesicles formed with mixtures of cytochrome caa3 and F1F0-synthase from alkaliphile 
B. pseudofirmus OF4 at various molar ratios and of mixtures of phospholipids 
vesicles of individual complexes. The molecular masses used in calculation of molar 
ratios were 517,000 and 105, 500 daltons for F1F0-synthase and cytochrome caa3, 
respectively. The ratio of phospholipids to protein was 1.5 by weight in all cases. 
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complex or a complex from a supermacromolecular complex, during the isolation. Such an 
interaction occurs only when a vesicle is formed. Little exothermic transition was observed 
in mitochondrial or submitochondrial preparations because there is no such exposed area 
in the native complex or supercomplex to interact with phospholipids under strained 
conditions. When two interacting complexes are mixed together before being embedded in 
phospholipids vesicles, the exposed area on the protein surface is greatly diminishes 
through the protein-protein interaction. Therefore, less strained interaction occurs upon 
vesicle formation, and less enthalpy change of exothermic denaturation is observed. It has 
been reported that thermodenaturation of the mitochondrial membrane under aerobic 
condition is accompanied by a heat release,which was attributed to the autooxidation of 
iron-sulfur protein (20). This explanation is not applicable to the present study because 
there are no iron-sulfur proteins in either cytochrome caa3 or F1F0-synthase. 
ST-EPR Studies of Spin-labeled Cytochrome caa3 Embedded in Phospholipid 
Vesicles in the Absence and Presence of F1F0-synthase--To confirm the existence of a 
specific interaction between cytochrome caa3 and F1F0-synthase, cytochrome caa3 was 
labeled with 4-maleimide-2,2,6,6-tetramethyl-1-piperidinyl-N-oxyl (MSL) as described 
under “Experimental Procedures”. This MSL-cytochrome caa3, which is enzymatically 
active, was embedded in phospholipids vesicles alone or together with F1F0-synthase. The 
electron paramagnetic resonance (EPR) measurements of these electron transfer complex-
phospholipid vesicles show typical spin-immobilized spectra. The spectra are identical 
regardless of whether the protein-phospholipid vesicles contained only cytochrome caa3 or 
cytochrome caa3 and F1F0-synthase complexes (see spectra A and B of Figure 28). This 
suggests that the difference in mobility of the spin-label on cytochrome caa3, in the 
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absence and presence of F1F0-synthase, is too small to be measured by conventional EPR. 
Therefore, the protein rotational diffusion of the spin-labeled complex was measured by 
saturation transfer electron paramagnetic resonance (ST-EPR). From the change of the 
ratio of two low-field signals (L’’/L) (see spectra C and D of Figure 28), rotational 
correlation times (τ2) can be calculated according to methods reported (14,15). Table 11 
shows the effect of additions on the rotational correlation time of spin-labeled cytochrome 
caa3. When mixed with F1F0-synthase from alkaliphilic Bacillus pseudofirmus OF4 before 
being embedded in phospholipids vesicles, a significance increase in τ2 was observed 
compared to that of spin-labeled cytochrome caa3 embedded in phospholipids vesicles 
alone. However, the τ2 of spin-labeled cytochrome caa3 was not affected by the addition of 
cytochrome bc1 complex or ATP-synthase from bovine heart prior to the formation of 
vesicles; and the mixture of spin-labeled cytochrome caa3 complex and F1F0-synthase 
phospholipids vesicles showed the same τ2 as that of cytochrome caa3 phospholipid 
vesicles alone (see Table 11). 
A similar effect of succinate-Q reductase on τ2 of spin-labeled ubiquinol-cytochrome 
c reductase (18), and of F1F0-synthase on τ2 of spin-labeled cytochrome c oxidase from 
bovine mitochondria (11), has been reported from this group. It is conceivable that at least 
part of the observed effect resulted from a change in the fluidity of the membrane by 
inclusion of protein complexes other than the spin-labeled complex. Also, it should be 
mentioned that the rotational correlation time obtained from ST-EPR is only an 
approximate value; it is based on the calibration curve derived from the isotropic motion 
of spin-label. The values obtained, however, agree with those obtained by other methods, 
such as flash photolysis (21). Although in this study our main concern is with the relative 
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τ2 of spin-labeled cytochrome caa3 in the absence and presence of the F1F0-synthase from 
alkaliphilic Bacillus pseudofirmus OF4, the τ2 values obtained are in agreement with the 
DSC data. 
From the results of DSC and ST-EPR experiments, we conclude that cytochrome 
caa3 and F1F0-synthase from alkaliphilic Bacillus pseudofirmus OF4 may exist as a 
supermacromolecular complex in the membrane. This conclusion differs significantly 
from the free diffusible model of electron transfer complexes derived from results of 
membrane fusing (22) and fluorescence recovery, after photobleaching, measurements 
(23). However, it has been clearly established that some mitochondrial electron-transfer 
complexes specifically interact to form supermolecular structures called supercomplexes 
from the work on the yeast Saccharomyces cerevisiae (24,25), beef (11,18,25,26), and 
plants (27-30). Similar supermolecular structures were also described for the respiratory 
chains of bacteria (31-35). The roles that have been attributed to respiratory 
supercomplexes are substrate-channeling, catalytic enhancement, sequestration of reactive 
intermediates (25), stabilization of protein complexes (36), increasing the capacity of the 
inner mitochondrial membrane for protein insertion (24), and generating mitochondrial 
cristae morphology (37). Furthermore, the dynamic formation of such supercomplexes is 
speculated to serve some regulatory function in the energy generation in mitochondria 
from plants (27) and beef (11). Similarly, the formation of a supermacromolecular 
complex between cytochrome caa3 and F1F0-synthase from alkaliphilic Bacillus 
pseudofirmus OF4 may help control energy generation in this alkaliphilic bacterium. The 
formation of supermacromolecular complexes from some electron transfer and F1F0-
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synthase complexes indicates that some of these complexes do not follow the random 





Figure 27. EPR spectra of spin-labeled alkaliphile B. pseudofirmus OF4 cytochrome 
caa3 in the absence and presence of OF4 F1F0-synthase complex. Spectra A and B are 
conventional EPR spectra of spin-labeled OF4 cytochrome caa3 embedded in phospholipid 
vesicles in the absence or presence of OF4 F1F0-synthase complex. Spectra C and D are 
the saturation transfer EPR spectra of the same samples. The protein concentrations were 6 






Table 11. Effect of additions on the rotational correlation time (τ2) of spin-labeled 
cytochrome caa31 
Preparations L’’/L τ2 (µs) 
(MSL-caa3 × PL) 0.70 65 
[(MSL-caa3 + bF1F02) × PL] 1.06 270 
[(MSL-caa3 × PL) + (bF1F0 × PL] 0.71 70 
[(MSL-caa3 + mF1F03) × PL] 0.71 70 
[(MSL-caa3 + mbc14) × PL] 0.70 65 
           1The molar ratio of cytochrome caa3 to other proteins used was 1:1. 
          2The bF1F0 was F1F0-synthase from bacterial alkaliphile B. firmus OF4. 
          3The mF1F0 was F1F0-synthase from bovine mitochondria. 
          4The mbc1 was cytochrome bc1 complex from bovine mitochondria. 
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